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Paradoxical vocal fold motion (PVFM) disorder, often referred to as vocal 
cord dysfunction (VCD), interferes with breathing because the vocal folds adduct 
during inspiration making it difficult to inhale. When PVFM is triggered by exercise, 
it can impact competitive play. Athletes with PVFM are often misdiagnosed as 
having exercise-induced asthma, but do not respond to asthma treatment. Directly 
visualizing the larynx (laryngoscopy) when symptoms are present is the current “gold 
standard” for diagnosing PVFM. However, laryngoscopy is invasive and expensive. 
Standardized noninvasive alternative methodologies are needed for clinically feasible 
assessment of PVFM by the speech-language pathologist.  Respiratory resistance (Rr), 
measured with the Airflow Perturbation Device (APD), may be useful for assessing 
PVFM because vocal fold adduction can increase Rr markedly.  
This research comprises three studies with an overarching goal to validate an 
objective, non-invasive measure of Rr for identifying abnormal constriction of the 
  
laryngeal airway associated with PVFM disorder. Study 1 compared APD-measured 
Rr to glottal area (GA) assessed through laryngoscopy in a healthy subject feigning 
PVFM-type breathing. Study 2 assessed intra- and intersession test-retest reliability of 
APD-determined Rr for a control group of 12 healthy female teenage athletes during 
resting tidal breathing (RTB) and post-exercise breathing (PEB). Study 3 examined 
differences between the same 12 healthy athletes with 12 athletes diagnosed with 
PVFM matched for sex, age, and activity level, for Rr, exercise duration, and dyspnea 
ratings for RTB and PEB.   
The results revealed: 1) a strong negative correlation (r = -0.824) between Rr 
and GA suggesting that the APD can indirectly measure changes in the laryngeal 
airway; 2) strong test-retest reliability for APD-measured inspiratory (Ri) and 
expiratory (Re) resistance during RTB (ICC  > .95), and PEB (ICC >.85); and 3) in 
control athletes, Ri and Re decreased during PEB as compared with RTB, whereas in 
athletes with PVFM, both Ri and Re increased during PEB with statistical significance 
reached for Ri (p <.001). During exercise, athletes with PVFM reported severe 
dyspnea and exercised for shorter durations. This research demonstrates that a 
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Chapter 1: Introduction 
The human vocal tract needs to perform several very different functions; to 
create sound for communication, it needs to be partially closed, yet, to breathe deeply, 
it must be fully open. To meet these contradictory needs, the vocal folds have to be 
capable of a great range of mobility and to accurately coordinate with the whole body 
system. They can approximate within the vocal tract, allowing for phonation, but also 
fully dilate to allow as much air as possible to pass through. Occasionally, the vocal 
folds may not move appropriately. Paradoxical vocal fold motion disorder (PVFM), 
previously referred to as vocal cord dysfunction (VCD), is a condition where the 
vocal folds adduct (close) during inspiration when they should abduct (open), 
decreasing airway patency. Although sporadic case reports have described symptoms 
suggestive of PVFM in the early literature, the disorder has not gained broad 
recognition until the past 15 years. Various triggers can lead to difficulty breathing 
(known as dyspnea) lasting for minutes to hours and prompting patients to seek 
medical care (Andrianopoulos, Gallivan, & Gallivan, 2000; Hicks, Brugman, & 
Katial, 2008). Patients are commonly misdiagnosed as having asthma, yet they do not 
respond to aggressive asthma therapy.  They can experience dyspnea for months to 
years without receiving an accurate diagnosis, causing physical, psychosocial, and 
financial consequences. Typically patients’ descriptions of their symptoms and results 
from pulmonary function tests suggest a diagnosis of PVFM. However, the most 
accurate method for diagnosis is direct visualization of the larynx when symptoms are 
present. This becomes a conundrum because of unpredictability of PVFM symptoms 




After PVFM is diagnosed, speech-language pathologists (SLPs) can provide 
behavioral therapy to teach patients to modify and control their breathing. First, 
however, there is a need for equipment and standardized methodologies so that 
diagnostic accuracy of PVFM can be improved. Thus, the overall purpose of this 
dissertation is to expand the current knowledge of PVFM, targeting diagnosis for 
teenage female athletes who experience exercise-induced PVFM. 
Overview 
Since first described by Jackson and Jackson in 1942 as “spasmodic closure of 
the glottis” (Gallivan, Hoffman, & Gallivan, 1996), there have been more than 70 
names used to describe PVFM in the literature (Hicks et al., 2008). The earliest 
diagnostic label was Munchausen’s Stridor (Patterson, Schatz, & Horton, 1974), 
described as intermittent vocal fold adduction during breathing attributed to a 
psychogenic etiology. Because the symptoms were often confused with those of 
asthma, it has also been called factitious asthma (Downing, Braman, Fox, & Carrao, 
1982). More commonly, the term vocal cord dysfunction (VCD) has been used, 
especially by medical practitioners in pulmonology (Christopher & Morris, 2010; 
Christopher et al., 1983; Newman, Mason, & Schmaling, 1995). The term 
“paradoxical” was first used by Rogers and Stell (1978) to describe the involuntary 
vocal fold adduction observed when vocal fold abduction should occur during the 
inspiratory phase of breathing (Powell et al., 2000). The label Paradoxical Vocal Fold 
Motion is preferred by SLPs and otolaryngologists (Divi et al., 2008; Hicks et al., 




Prevalence data for patients with PVFM are typically reported for two groups 
of individuals – those presenting to hospitals and clinics with dyspnea originally 
thought to be caused by asthma, and athletes experiencing breathing problems during 
exercise. Hicks et al. (2008) reported that 2.8% of 1,025 patients seen at a pulmonary 
center had PFVM. Rundell and Slee (2008) diagnosed PVFM in 2.4% of a group of 
370 elite athletes.   
PVFM has been reported across the life span in individuals as young as 2 
months and up to 82 years of age (Hicks et al., 2008). In Hicks et al.’s review, 65% of 
the patients with PVFM were adults and 35% were children under the age of 19 
(Hicks et al., 2008). Young female athletes seem to be a group with particularly high 
prevalence of PVFM. Among pediatric athletes, the average age at the time of 
diagnosis is 14 years (Powell et al., 2000; Sandage & Zelanzny, 2004).  
With regard to gender, more females are reported to have PVFM, with 
reported female-to-male ratios ranging from 2:1 (Hicks et al., 2008), 4:1 (Powell et 
al., 2000), to 9:1 (Patel, Jorgensen, Kuhn, & Merati, 2004). Following a chart review 
of 95 adult patients with PVFM and combined PFVM and asthma, Newman et al. 
(1995) described  the typical PVFM  patient as young, white (40 of 42), and female 
(41 of 42) (p. 1383). A chart review of 265 consecutive patients diagnosed with 
PVFM  (127 active duty and 138 non-active-duty retirees and dependents) seen at 
Walter Reed Army Medical Center, revealed in the non-active-duty patients a female-
to-male ratio commensurate with what is commonly reported in the literature. For the 
active-duty patients in an overwhelmingly male profession – the female-to-male ratio 




There are many symptoms associated with PVFM, the most common being 
dyspnea (Andrianopoulos, Gallivan, & Gallivan, 2000; Hicks, Brugman, & Katial, 
2008). Because the area of constriction is at the larynx, stridor (a phonation-like 
sound that is produced by the approximated vocal folds) is generated, most often 
during inspiration (Andrianopoulos et al., 2000; Brugman & Simons, 1998). 
According to Koufman and Block (2008), the pattern and high-pitched sound of 
stridor differentiate upper airway obstruction (i.e., PVFM) from lower airway 
obstruction (i.e., asthma). Individuals with PVFM consistently identify the neck, 
throat and upper chest as areas of perceived constriction. It is reported as a choking 
sensation (Andrianopoulos et al., 2000; McFadden & Zawadski, 1996) and although it 
causes abrupt and transitory airway compromise, hypoxemia (oxygen deprivation) is 
rarely reported (Hicks et al., 2008). Increased upper torso muscle tension is 
manifested with suprasternal (upper chest) and neck muscle retraction (Brugman & 
Simons, 1998). Frequently, cough co-occurs, explained by some as part of the PVFM 
syndrome (Altman, Mirza, Ruiz, & Sataloff, 2002; Morrison, Rammage, & Emami, 
1999; Vertigan, Theodoros, Gibson, & Winkworth, 2006, 2007).  Others have 
suggested that cough is used as an attempt to briefly abduct (open) the vocal folds 
during breathing difficulty (Brugman & Simons, 1998). Vocal hoarseness (also 
known as dysphonia) frequently accompanies PVFM. Some have explained 
dysphonia as a result of vocal fold tension secondary to PVFM, creating muscle 
tension dysphonia (Morrison et al., 1999). Others explain dysphonia as a consequence 
of laryngeal constriction and vocal fold swelling occurring during an episode of 




rapid breathing, dizziness, numbness of the extremities- are frequently associated 
with PVFM (Hicks et al., 2008). In addition to physical symptoms, feelings of 
anxiety, fear and panic are commonly reported by those with PVFM because of the 
frightening nature and sudden onset of the symptoms (Brugman & Simons, 1998).
 Because of the variability in symptoms and triggers of PVFM, some have 
proposed that it is a syndrome (Heinle, Linton, & Chidekel, 2003; Morrison et al., 
1999). Maschka and colleagues (1997), described PVFM as “a group of disorders 
which share the common finding of mobile vocal cords that adduct inappropriately 
during inspiration” (p.1429). This statement appropriately summarizes the variability 
and consistency of PVFM.  
Anatomical and Physiological Aspects of PVFM 
Anatomy and physiology of the larynx.  Prior to understanding PVFM, a 
review of the anatomy and physiology of the larynx is necessary. The larynx is vital 
to airway protection, ventilation, and phonation, however, the latter (phonation) will 
not be discussed since the focus of this research is primarily on ventilation. During 
breathing, the larynx (generally), including the vocal folds, (specifically) has unique 
sensory and motor functions that allow unimpeded respiration, as well as airway 
protection.  The upper airway can be functionally divided into thirds – the supraglottis 
(the laryngeal structures superior to the vocal folds), the glottis (the opening between 
the vocal folds) and the subglottis (the laryngeal area immediately below the vocal 
folds). The tenth cranial nerve (Vagus nerve) branches off in the neck to form the 
superior laryngeal nerve (SLN) and the recurrent laryngeal nerve (RLN). The SLN 




fibers innervating the paired cricothyroid muscles.  The RLN branch supplies 
sensation for the subglottis and movement for the remaining intrinsic laryngeal 
muscles, including the thyroarytenoid muscles that form the muscular portion of the 
vocal folds.  Efferent fibers of the Vagus nerve start in the somatosensory gyrus and 
partially decussate before synapsing with the motor neurons in the nucleus ambiguus 
in the medulla. The nucleus ambiguus receives bilateral motor input from the cortex 
as well as sensory input from the nucleus solitarius. This network allows the vocal 
folds to function simultaneously (Balkissoon, 2007; Colton, Casper, & Leonard, 
2006). 
 While most of the intrinsic laryngeal muscles function as vocal fold adductors, 
the paired posterior cricoarytenoid (PCA) muscles widen the glottis by abducting the 
vocal folds. The paired cricothyroid muscles function to change vocal pitch, but may 
have an abductory influence based upon the findings of Woodson (1990), who 
investigated respiratory activity of the cricothyroid muscle in six healthy participants. 
During a deep breath respiratory maneuver, cricothyroid activity was observed during 
both inspiration and expiration, suggesting that it may work with the posterior 
cricoarytenoid in certain tasks to maximally open the glottis.  A serial relationship 
exists between the activation of the PCA muscles and the diaphragm for inspiration, 
such that contraction of the PCA opens and stiffens the airway before diaphragmatic 
contraction creates negative inspiratory pressure allowing airflow without obstruction 
(Eichenwald , Howell, Kosch, Ungarelli, & Stark 1992). Eichenwald et al. (1992) 
studied this relationship in full term and preterm infants and observed that for most 




the babies when diaphragm activation led PCA muscle activation. In their study, this 
occurred unpredictably for a mean of 33% (and range of 6 – 61%) of the analyzed 
breaths. They questioned if this finding was unique to infants. Ruddy et al. (2004) 
employed a stringent program of inspiratory muscle training to successfully treat an 
athlete with PVFM. The researchers hypothesized that based upon the diaphragm and 
PCA relationship, increased movement of the diaphragm during inspiration might 
cause increased contraction of the PCA muscle, allowing those with PVFM to 
volitionally widen the glottis.  
          In addition to its function during respiration, the larynx also provides protection 
to the lower airway through reflexive actions that close the glottis (Hicks et al., 2008) 
and/or elicit cough. Laryngeal sensory receptors respond to temperature changes 
(cold), chemical irritants (including water and aerosols), pressure, and motion (Hicks 
et al., 2008). Chemoreceptors in the laryngeal mucosa (located in the interarytenoid 
space) trigger glottal closure in response to fluid in the upper airway (Thach, 1997). 
The glottal closure reflex is a three-tier action beginning with constriction of the 
aryepiglottic folds, whereby the arytenoid cartilages fold over the posterior glottis as 
the epiglottis inverts to protect the anterior airway. The next two protective tiers are 
adduction of the ventricular (false) folds and adduction of the true vocal folds. This 
serves to protect the lower airway from irritants resulting from refluxed materials and 
cough (Koufman & Block, 2008). In some instances, PVFM may occur to close and 
protect the airway from irritants (Morrison, Rammage & Emami, 1999). 
Ventilation. Breathing (involving gas exchange for oxygenation of the blood) 




the cortex. While sleeping one has no awareness of their breathing, yet when awake, 
one can choose to take control of their breathing for short durations. Breathing is 
accomplished through active and passive muscle contraction and relaxation and is 
divided into two phases – inspiration and expiration – with different vocal fold 
positions occurring during each phase. The main respiratory muscle of inspiration is 
the large, dome-shaped diaphragm that sits below the lungs and separates the thorax 
from the abdomen.  
During inspiration for rest (also referred to as tidal or eupneic) breathing, 
widening of the glottis is usually accomplished through contraction of the paired PCA 
muscles milliseconds before diaphragmatic activation occurs (Eichenwald et al., 
1992). This allows for unimpeded airflow through the laryngeal airway to the lungs 
created by a negative thoracic pressure change caused by thoracic and abdominal 
expansion (Aronson, 1990; Hixon & Hoit, 2005). The glottis typically achieves its 
maximum width at mid-inspiration (Beaty, Wilson, & Smith, 1999) and although this 
occurs primarily through activation of the PCA muscle, partial muscle activation of 
the adductor muscles has been observed during electromyographic studies (Maschka 
et al., 1997; Woodson, 1990). 
Slight medial movement of the vocal folds normally occurs during the 
expiratory phase for rest breathing. Less than 30% narrowing of the glottis from 
inspiration to expiration (Balkissoon, 2007) is typical, although there is variability 
across individuals.  This medial movement serves the purpose of slowing the exhaled 




Haight, 1993; Mathers-Schmidt, 2001), that in turn, maintains the alveolar patency of 
the lungs (Koufman & Block, 2008). 
Breathing during physical activity differs from resting tidal breathing (RTB) 
with regard to change in glottal area.  There is a need for maximum vocal fold 
abduction during exercise to accommodate increased airflow turbulence (Beaty et 
al.,1999;  Silverman, Johnson, Scott, & Koh, 2005b). Beaty et al. (1999) observed 
laryngeal changes in eight healthy controls during exercise using flexible 
nasoendoscopy and noted that, as the exercise work load increased, five of the 
participants experienced increased laryngeal lumen size (the cross-sectional area 
between the abducted vocal folds at mid-inspiration), while the three remaining 
athletes experienced no change. They also observed two participants with PVFM, and 
noted that laryngeal lumen size decreased during exercise coincident with dyspnea 
and stridor. For the control athletes, other changes in the larynx were observed during 
exercise. The supraglottic larynx dilated and rotated anteriorly and the epiglottis 
flattened against the base of the tongue to improve the efficiency of airflow and 
minimize resistance in the airway. For the two participants symptomatic of PVFM, 
when the supraglottic larynx dilated and moved forward, the posterior larynx 
collapsed into the airway and the vocal folds moved medially from their previous 
fully abducted position, thus decreasing the laryngeal lumen consistent with exercise-
induced laryngomalacia (Beaty et al., 1999). Silverman and colleagues (2005b) 
assessed respiratory resistance (Rr), while controlling  for flow rate, in 12 healthy 




rest levels quickly after exercise ceased (within 55 seconds for Rr during inspiration 
and 35 seconds for Rr during expiration).   
Classification Models and Hypotheses for PVFM  
Differing triggers and symptom patterns have led to proposals of classification 
models (or subtypes) of PVFM disorder.  Most of these models hypothesize etiologies 
and underlying laryngeal neurophysiology based upon PVFM-triggering stimuli 
without strong scientific evidence. When discussing etiologies for PVFM, there are 
overlapping reports of triggering stimuli that initiate PVFM symptoms. First, a 
summary of the published classification models and proposed etiologies for PVFM 
will be presented, followed by a discussion of PVFM triggers. 
The earliest models recognized a distinction between organic and nonorganic 
etiologies for PVFM.  Maschka et al. (1997) included brainstem compression, upper 
motor neuron injury, lower motor neuron injury, movement disorder, and reflux as 
organic causes for PVFM. Nonorganic causes included psychological conditions and 
malingering. Altman et al. (2000) proposed a similar model, citing laryngeal dystonia 
(a neurological movement disorder) and psychogenic (conversion) etiology as causes 
for PVFM. Mathers-Schmidt (2001) made a further distinction, delineating three 
categories of PVFM: neurologic, psychogenic, and upper airway sensitivity. Divi et 
al. (2008) expanded the classification further by including a descriptor of laryngeal 
physiology (supraglottic collapse with vocal fold hypomobility) in addition to 
neurologic, psychiatric and laryngeal irritability. Christopher and Morris (2010) used 
the term “periodic occurrence of laryngeal obstruction” (POLO), as a general term for 




psychological disorders. According to Christopher and Morris (2010), VCD is 
complete although intermittent adduction of the vocal folds; PVFM is paradoxical yet 
symmetrical motion during inspiration; and intermittent arytenoid region prolapse is 
comparable to laryngomalacia. Koufman and Block’s (2008) etiology-based model 
for PVFM seems most detailed and includes: 1) reflux; 2) asthma and hyper-immune 
disorders; 3) psychogenic stridor; 4) respiratory-type dystonia and brainstem 
abnormalities; and the relatively rare 5) drug-induced dystonia. Their model, 
however, did not recognize exercise-induced PVFM.  
The pathophysiology of PVFM is unknown and may differ depending upon 
symptom presentation and triggering stimuli. Christopher and Morris (2010) 
recognized this when they posed the rhetorical question: “Is the endoscope used to 
visualize a limited number of end-organ laryngeal responses without fully 
understanding the spectrum of causes that are literally hidden from sight?” (p. 44).  
One theory proposes that hypersensitivity and hyper-reactivity of the larynx 
and vocal folds from repeated exposure to a triggering stimulus results in a 
heightened glottal closure reflex (Newman et al., 1995; Morrison, et al., 1999; Hicks, 
et al., 2008). Morrison and colleagues (1999) expanded this by developing the 
“Irritable Larynx Syndrome,” suggesting that PVFM is caused by altered central 
neuronal control of the larynx (neural plasticity). After repeated exposures to 
triggering stimuli, neural changes to the central brainstem nuclei occur such that the 
larynx stays in a “spasm ready” state, needing only the stimulus to trigger PVFM.  
Cukier-Blaj, Bewley, Aviv and Murry (2008) tested laryngeal sensitivity in 75 




cough) and found them to have lower-than-normal laryngeal reflex thresholds. By 
delivering a calibrated puff of air to the left and right aryepiglottic folds to stimulate 
the laryngeal adductor reflex, their patients were found to have reduced laryngeal 
sensation (hyposensitivity) compared with pre-established norms. The researchers 
hypothesized that PVFM in patients who have reflux results from a laryngeal sensory 
deficit manifesting in a compensatory hyper-reactivity of the vocal fold closure reflex 
in order to protect the upper airway.   
It could be argued that neither of the above hypotheses – hyposensitivity or 
hypersensitivity from repeated exposure – account for instances in which an 
individual has a single exposure (i.e., a work related chemical exposure) yet continues 
to experience PVFM when no longer in the presence of that original trigger. Hicks et 
al. (2008) explained this as a “priming effect,” where the original trigger is absent, yet 
previously benign irritants become new triggers.  Mathers-Schmidt (2001) described 
a transfer of symptoms, whereby those that occurred in only one setting (i.e., 
exercise) begin to be seen in other situations (i.e., test taking).  
Neurological explanations for PVFM are directly related to the site of lesion 
within the central or peripheral nervous systems and can often be validated by the 
pattern of symptoms, the presence of other comorbidities, and the response to 
treatments. Respiratory-type adductor laryngeal dystonia is one of the most common 
signs of several different neurological conditions (Blitzer & Brin, 1991; Koufman & 
Block, 2008).  It is characterized by continual (versus episodic) symptoms that 
worsen when the individual breathes deeply, and are present during wakefulness but 






) injections in the thyroarytenoid muscles (Blitzer & Brin, 1991; Koufman & 
Block, 2008). Other conditions such as brainstem abnormalities associated with 
trauma, disease, and stroke may cause consistent PVFM symptoms that are present 
during sleep as well as wakefulness (Koufman & Block, 2008; Maschka et al., 1997).   
In some individuals, recent respiratory tract infections appear to precede the 
onset of PVFM ( Hicks et al., 2008; Koufman, 1994; Koufman & Block, 2008; 
Maschka et al., 1997; Morrison et al., 1999). In 17 of the 39 patients studied by 
Morrison and colleagues (1999), onset of PVFM followed a recent viral infection. It 
is well documented that asthma can be triggered by viral infections. Hicks and 
colleagues (2008) question if the same mechanism can cause upper airway hyper-
responsiveness resulting in PVFM. A possible neurological explanation for PVFM 
following an initial inflammatory event such as a virus was discussed by Ayres and 
Gabbott (2002). They proposed that laryngeal hyper-responsiveness resulted from “an 
altered autonomic balance” (p.284).  Increased activity within the areas of central 
brain regions that are linked with the larynx cause a change in the 
parasympathetic/sympathetic nervous system output that heightens the glottic closure 
reflex. This autonomic preset, according to the authors, can be temporary or long-
lasting.  
Structural laryngeal explanations have also been suggested. Posterior 
laryngeal collapse of the arytenoid and corniculate cartilages causing or synchronous 
with vocal fold adduction has been a common finding in athletes presenting with 
PVFM symptoms.  Alteration in the anatomy of the larynx during pubescent growth 




account for PVFM in adolescents. Several changes associated with the maturing 
larynx occur between the ages of 10 – 14 years (and for some beyond the age of 14): 
the vocal folds lengthen, and the cartilages change in malleability, size, and shape. 
The narrowest part of the larynx moves from the subglottis in children to the glottis in 
adults (Sapienza, Ruddy, & Baker, 2004). 
Psychological health and emotions are associated with changes in breathing 
patterns (Boiten, Frijda, & Wientjes, 1994). Psychological explanations for PVFM are 
mentioned briefly in the Irritable Larynx Syndrome model (Morrison et al., 1999) as 
well as the Altered Autonomic Balance model (Ayres & Gabbott, 2002). A study 
describing 42 hospitalized patients with PVFM (Newman et al., 1995) revealed that 
22% had prior psychiatric hospitalizations, leading the authors to conclude that 
individuals with PVFM are a psychiatrically impaired group. It should be noted that 
their sample was taken from a hospitalized group, which could have impacted the 
results.  Maschka et al. (1997) described two non-organic subtypes of PVFM –  
factitious/malingering, and somatization/conversion (p. 1430). Others have also 
regarded PVFM as a conversion disorder where physical manifestation (somatization) 
of anxiety or stress is motivated by secondary gain, providing benefit from their 
PVFM symptoms (Christopher et al., 1983).  Gavin, Wamboldt, Brugman, Roesler, 
and Wamboldt (1998) evaluated personality and family characteristics of children 
with PVFM, and noted increased anxiety in the youth with PVFM, some of whom 
had separation anxiety which is thought to be a precursor to panic anxiety in 
adulthood.  According to Gavin et al. (1998), the primary physiological abnormality 




chemosensor system” (p. 416). The overlapping symptoms of panic anxiety and 
PVFM lead the authors to question whether the brainstem respiratory area might be 
implicated in those with psychogenic PVFM. In addition to anxiety and stress, 
depression was a significant influence in a study comparing personality 
characteristics in different categories of voice and laryngeal disorders (Dietrich, 
Verdolini-Abbott, Gartner-Schmidt, & Rosen, 2008).   
Triggers for PVFM 
Laryngopharyngeal reflux (LPR).  Perhaps the triggering stimulus reported 
most often for PVFM in children and adults is reflux (Andrianopoulos et al., 2000; 
Balkissoon, 2007; Gurevich-Uvena et al., 2010; Koufman & Block, 2008; Morrison 
et al., 1999; Powell et al., 2000). LPR is characterized by a backflow of gastric 
contents into the larynx and pharynx (Balkissoon, 2007). Typical symptoms of 
gastroesophageal reflux disease (GERD), such as heartburn, are not common to LPR; 
rather, LPR is associated with cough, throat clear, dysphonia, and PVFM. As few as 
three LPR episodes per week can lead to significant laryngeal damage (Balkissoon, 
2007).  In canine models, exposure of supraglottic receptors to a pH environment of 
2.5 or lower from gastric fluid provoked laryngospasm (reflexive tight glottal closure) 
through reflexes mediated by the vagus nerve (Koufman & Block, 2008). LPR can 
cause swelling of the laryngeal structures that can further reduce laryngeal lumen size 
and increase resistance to airflow (Powell et al., 2000). Laryngeal changes caused by 
LPR, such as edema, thickened secretions, and space-occupying lesions, are reported 
in those with PVFM (Colton, Casper, & Leonard, 2006; Cukier-Blaj et al., 2008). 




laryngeal tissue damage secondary to reflux. A study by Morrison and colleagues 
(1999) revealed that 85% of 39 patients with PVFM had evidence of LPR. Cukier-
Blaj et al. (2008) reported that reflux was diagnosed in 70.4% of 75 patients 
diagnosed with PVFM. Strenuous exercise is hypothesized to induce reflux because 
of  a reduction in gastric blood flow causing reduced gastric emptying and decreased 
motility and pressures of the esophagus (Jozkow, Wasko-Czopnik, Medras, & 
Paradowski, 2006; Richter et al., 2008). Body postures and strain associated with 
exercise also may cause refluxed material to enter the laryngeal inlet (Jozkow et al., 
2006; Richter et al., 2008). The LPR-PVFM connection appears to be protective such 
that the glottic closure reflex is on high alert in response to LPR. 
Airway irritants. Allergic rhinitis or sinusitis with post-nasal drip has been 
implicated in PVFM (Brugman & Simons, 1998; Morrison et al., 1999). Inhaled 
allergens are hypothesized to cause throat clearing, coughing, and post-nasal drip, 
which result in hypersensitivity of the airway. Brugman and Simons described this as 
a “twitchy airway” (p. 66), whereas Morrison et al. (1999) considered inhaled 
allergens as one of many triggers that over time keeps the airway in a “spasm-ready” 
state, adducting the vocal folds to protect the lower airway. Many patients with 
PVFM describe onset of their symptoms from exposure to inhaled airborne 
substances (Balkissoon, 2007; Morrison et al., 1999). Commonly identified triggers 
are strong fumes (paint or gasoline) or certain fragrances (perfumes and candles). 
Gartner-Schmidt, Rosen, Radhakrishnan, and Ferguson (2008) found that when odors 
were presented transnasally to a blindfolded person with odor-induced PVFM, her 




irritant challenge was repeated with her nose occluded, requiring her to breathe 
through her mouth, throat closure occurred for only one irritant, suggesting that 
different levels of sensitivity may be associated with olfaction. Asthma appears to be 
a trigger for PVFM when the two co-occur, yet many patients with PVFM are 
initially misdiagnosed as asthmatic. The same conditions and stimuli, such as  
allergens, chemicals, strong fragrances (Koufman et al., 2008), high humidity 
experienced by swimmers (Langdeau et al., 2000), and cold and dry air experienced 
by athletes of winter sports (Rundell & Spiering, 2003), can trigger both conditions. 
Psychological.  Extreme emotion, anxiety, and stress are associated with the 
onset of PVFM (Andrianopoulos et al., 2000; Gavin et al., 1998; Husein et al., 2008; 
Patterson et al., 1974; Ramirez, Leon, & Rivera, 1986; Wamboldt & Wamboldt, 
2008). Anxiety has long been recognized as comorbid with respiratory symptoms as 
observed in panic anxiety (with hyperventilation) and post-traumatic stress disorder 
(Baker, 2003). Anxiety, competitiveness, intolerance of personal failure, and Type A 
personality characteristics have been reported frequently in athletes with PVFM 
(Brugman & Simons, 1998; Newsham, Klaben, Miller, & Saunders, 2002). They have 
been described as “choking” during sports participation because of their inability to 
perform to expectations at critical and emotionally laden times (McFadden & 
Zawadski, 1996, p.942).  In a study by Powell et al. (2000), 55% of athletes with 
PVFM reported experiencing a high level of social stressors, especially associated 
with sports performance. Brugman and Simons (1998) caution that anxiety and stress 




  Exercise. PVFM triggered by exercise (i.e., exercise-induced PVFM or 
EIPVFM) is frequently reported in athletes and active duty military (Gurevich-Uvena 
et al., 2010). The typical profile of an athlete with PVFM is a female adolescent or 
teen, competitive high- performing athlete, who has been misdiagnosed with exercise-
induced asthma  (Beaty et al., 1999; Christopher et al., 1983; Heinle et al., 2003; 
Landwehr, Wood, Blager, & Milgrom, 1996; Langdeau et al., 2000; Mathers-
Schmidt, 2001; Newsham et al., 2002; Rundell & Spiering, 2003).  The athlete may 
be forced to discontinue her sport because of PVFM symptoms that negatively impact 
performance (Brugman & Simons, 1998; McFadden & Zawadski, 1996).  A rapid 
onset of symptoms that resolve with cessation of exercise and a lack of 
responsiveness to asthma medications are further indicators of PVFM (Brugman & 
Simons; Hicks et al., 2008; Mathers-Schmidt, 2001; Newsham et al., 2002; Sandage 
& Zelanzny, 2004). Prevalence data lack reliability since so many athletes with 
PVFM are misdiagnosed as having asthma. However, Brugman and Simons estimated 
that 3% of the collegiate level athletes with a history of activity induced respiratory 
distress have PVFM. In a study of 370 athletes, Rundell and Spiering (2003) found 
that 5% had inspiratory stridor consistent with a diagnosis of PVFM.  
Differential Diagnosis of PVFM   
PVFM must be differentiated from other organic and non-organic disorders of 
the larynx and vocal folds that can also impact breathing and produce stridor. When 
severe, adductor spasmodic dysphonia (ADSD), a focal dystonia causing adductor 
voice spasms, may be described as eliciting a “choking” feeling and may create 




the vocal folds (Hicks et al., 2008). When not phonating, however, persons with 
ADSD should experience unimpeded breathing (Balkissoon, 2007; Koufman & 
Block, 2008). Bilateral adductor vocal fold paralysis, interarytenoid web and 
cricoarytenoid joint fixation can also cause upper airway constriction (Maschka et al., 
1997). These disorders can be diagnosed through laryngoscopy and distinguished 
from PVFM by the presentation of persistent breathing symptoms as opposed to the 
transient nature of most subtypes of PVFM.  Acute onset of stridor and dyspnea 
caused by airway obstruction related to trauma, foreign body and infection should be 
accurately diagnosed through the case history, symptom pattern, and specific 
diagnostic tests (Balkissoon, 2007; Maschka et al., 1997) .  
Exercise-induced hyperventilation resembles PVFM. Common symptoms of 
hyperventilation include chest tightness, difficulty breathing, rapid breathing, 
dizziness and numbness of the extremities resulting from a reduction of carbon 
dioxide in the blood (also known as hypocapnia) from breathing too rapidly or too 
deeply. A reduced level of end tidal carbon dioxide helps to confirm a diagnosis of 
hyperventilation (Hammo & Weinberger, 1999).   
Most challenging is distinguishing PVFM from asthma, especially in athletes 
and individuals experiencing both conditions. Asthma involves bronchoconstriction 
(tightness) of lower airways as opposed to constriction of the upper airway for PVFM 
(Christopher et al., 1983). When asthma symptoms are provoked only by exercise or 
exertion, it is referred to as exercise-induced asthma (EIA) or exercise-induced 
bronchospasm (EIB). There are characteristics of PVFM that clearly distinguish it 




PVFM and asthma differ with regard to locus of constriction (throat versus 
chest), breath sounds (stridor rather than wheeze), and affected breathing phase 
(inspiration versus expiration) (Andrianopoulos et al., 2000; Brugman & Simons, 
1998; Mathers-Schmidt, 2001). When the vocal folds of a symptomatic asthma 
sufferer are visualized through laryngoscopy, increased adduction of the vocal folds 
may be observed during expiration for stabilization of ventilation (Balkissoon, 2007; 
Hurbis & Schild, 1991; Mathers-Schmidt, 2001). This is in contrast to adduction that 
is observed primarily during inspiration for PVFM.  A negative response to asthma 
medicines seems to be the hallmark diagnostic predictor of PVFM for those 
misdiagnosed as having asthma (Altman et al., 2000; Andrianopoulos et al., 2000; 
Balkissoon, 2007; Brugman & Simons, 1998; Christopher et al., 1983; Gallivan et al., 
1996; Heinle et al., 2003; Hicks et al., 2008; Landwehr et al., 1996; Martin, Blager, 
Gay & Wood, 1987; Mathers-Schmidt, 2001; McFadden & Zawadski, 1996; Sandage 
& Zelanzny, 2004).   
 The patterns of symptoms differ between the two conditions. Asthma requires 
more time for resolution of symptoms than PVFM (Brugman & Simons, 1998). 
Pulmonary function tests performed several weeks following a severe asthma attack 
can still detect abnormalities (Mathers-Schmidt, 2001). Exercise-induced PVFM 
symptoms often resolve within minutes after ceasing exercise, yet will recur when 
strenuous exercise resumes (Brugman & Simons, 1998; Hicks et al., 2008; Powell et 
al., 2000). Onset of asthma is frequently during sleep (nocturnal), whereas there are 
few accounts of nocturnal onset of PVFM  (Koufman & Block, 2008; Mathers-




PVFM (two of whom may have had comorbid asthma).  In contrast, patients 
experiencing PVFM typically report that sleep re-establishes comfortable breathing. 
  Asthma is diagnosed by pulmonary function tests (PFTs) such as spirometric 
measures of forced expiratory volume in one second (FEV1), and the ratio of forced 
expiratory flow to forced inspiratory flow under different provocation challenges 
involving medication administration or conditions established to purposefully 
provoke symptoms (Mathers-Schmidt, 2001; Seiner, Staudenmayer, Koepke, Harvey, 
& Christopher, 1987). Another diagnostic spirometric measure is the ratio of forced 
expiratory flow at mid-expiration to forced inspiratory flow at mid-inspiration (FEF50/ 
FIF50). For this particular diagnostic test, a quotient less than 1.0 is suggestive of 
asthma, whereas a quotient greater than 1.0 suggests upper airway involvement 
(Hicks, et al., 2008).  The percentage of oxygen concentration carried by arterial 
blood measured through pulse oxymetry or arterial blood gas sampling typically 
reveals decreased oxygenation during an asthma attack. Hicks and colleagues (2008) 
reviewed case studies where oxygen concentration levels were sampled during PVFM 
episodes. They concluded that over 75% of the patients had normal blood oxygen 
levels despite their apparent respiratory distress. None of the 17 female teenage 
athletes with PVFM investigated by Heinle et al. (2003) experienced decreased 
oxygen saturation during an exercise challenge.  
However, asthma and PVFM may co-exist. Hicks et al. (2008) reviewed the 
literature and reported that 40% of children and 38% of adults with PVFM had co-
existing asthma. Newman and colleagues (1995) reported that 56% of their patients 




52% of the athletes with “inspiratory stridor” (i.e., a sign consistent with PVFM) had 
exercise-induced bronchospasm (i.e., asthma). Confirming both conditions requires 
obtaining a positive result for a lower airway bronchial provocation challenge in 
conjunction with a positive finding of PVFM through laryngoscopic examination 
(Hicks et al., 2008).  Patients having both conditions can often distinguish differences 
in their symptoms and describe each with accuracy (Sandage & Zelanzny, 2004). 
Complications such as unnecessary drug use, hospitalization, tracheotomy, and 
intubation arise when patients with PVFM are treated as asthmatic (Heinle et al., 
2003;  Newman et al., 1995). In a retrospective chart review of 95 patients with 
confirmed PVFM, Newman et al. (1995) reported that 81% had been treated with 
high doses of corticosteroids for severe asthma for an average of 4.8 years.  The 
complications of unnecessary corticosteroid use can be severe, resulting in significant 
adrenal suppression (Heinle et al., 2003). Thus it is of extreme importance to 
accurately diagnose PVFM, while excluding other disorders with similar symptoms.   
Diagnosing PVFM Disorder 
PVFM is most accurately diagnosed by integrating information from the case 
history, symptom description, clinical examinations and provocation challenges. A 
multidisciplinary team should include the specialties of speech-language pathology, 
pulmonology, otolaryngology, and psychology.  The SLP contributes greatly to the 
team through his or her experience in behavioral treatment and knowledge of the 
larynx (Sandage & Zelanzny, 2004). Laryngeal examination is recognized by the 
American Speech-Language-Hearing Association as within the SLP’s scope of 




disorders of the vocal folds and larynx, can contribute to the team by describing the 
physiology of the larynx and vocal folds during asymptomatic and symptomatic 
periods of PVFM.  
Laryngeal assessment. Observation of the larynx when the patient is 
symptomatic of PVFM provides the defining criterion for diagnosis (Brugman & 
Simons, 1998).  Typically, the larynx is examined through flexible transnasal 
laryngoscopy or rigid transoral stroboscopy. Flexible laryngoscopy allows the 
clinician to visualize the nasopharynx, pharynx, and larynx providing information 
about allergic rhinitis, post-nasal drip, as well as signs of reflux (Balkissoon, 2007) . 
When the scope is passed through the nose, instead of the mouth, the patient can 
produce various speech tasks that help rule out conditions such as spasmodic 
dysphonia. Respiratory maneuvers such as panting and sniffing, are potentially easier 
to perform during endoscopy with a transnasally placed flexible scope, than during 
endoscopy with an orally placed rigid scope. (Maschka et al., 1997; Powell et al., 
2000; Sandage & Zelanzny, 2004). Provocation challenges such as exercise have 
been conducted with the flexible scope transnasally passed throughout the challenge 
(Beaty et al., 1999; Gartner-Schmidt et al., 2008; Heinle et al., 2003; Tervonen, et al., 
2009), allowing real-time monitoring of vocal fold motion and laryngeal changes.  
Rigid transoral laryngoscopy has been used successfully for diagnosing 
PVFM in approximately 70% of the athletes seen at the Loyola Clinical Center.  The 
primary reason for failure in the remaining patients is a strong gag reflex elicited by 
the rigid scope that prevents visualizing the larynx. Advantages of its use are the 




Powell et al. (2000) criticized this method, noting that of eight participants examined 
with oral (rigid) endoscopy, six were erroneously described as having a posteriorly 
displaced epiglottis. The investigators cautioned that the use of oral endoscopy may 
introduce confounding factors.  
There are problems associated with laryngoscopy for diagnosing PVFM. It is 
somewhat invasive and cannot be tolerated by everyone (Rundell & Slee, 2008; 
Rundell & Spiering, 2003). Furthermore, timing the placement of the scope with the 
occurrence of symptoms can be challenging. Inconsistency of the symptoms 
sometimes prevents documentation of PVFM despite clinically convincing signs and 
symptoms (Christopher & Morris, 2010).  Availability, expense, and equipment 
limitations must be considered as well.  
Laryngeal findings for PVFM symptoms. During PVFM episodes, various 
laryngeal findings have been observed. These include: 1) adduction of the anterior 
aspect or the full length of the vocal folds, and 2) prolapse of the posterior aspect of 
the larynx, most commonly referred to as laryngomalacia. Each of these will be 
described. 
Adduction of the anterior two thirds of the vocal folds with abduction of the 
arytenoid cartilages results in the classic “diamond shape” glottic gap for PVFM 
(Christopher, et al., 1983).  In a review of the PVFM literature, however, Hicks and 
colleagues (2008) reported that only 6% of cases reported this closure pattern.  In 15 
athletes presenting with significant laryngeal findings during exercise, only four 
demonstrated the classic PVFM pattern, whereas the other eleven had exercise-




al., 2003). Complete adduction of the vocal folds is also frequently reported, with 
some degree of movement during breathing (Balkissoon, 2007; Brugman & Simon, 
1998; Hicks et al., 2008).  The adductory motion is present predominantly on 
inspiration, but it may continue into expiration beyond what is typical during 
expiration as well. Brugman and Simons (1998), observed this in 50% of patients 
with PVFM.  They cautioned, however, that adductor motion on expiration alone 
should not be considered PVFM, as this can be an adaptive ventilatory response to 
lower airway constriction.   
Laryngomalacia refers to abnormal laryngeal motion in the posterior 
(arytenoid) region with prolapse of the glottic structures into the airway during 
inspiration (Beaty et al., 1999; Christopher & Morris, 2010; Heinle et al., 2003; 
Richter et al., 2008).  This diagnostic term was originally given to newborns during 
the first year of life if they presented with inspiratory stridor that was attributed to 
underdeveloped upper airway muscle tone and laryngeal cartilages (Richter et al., 
2008). Divi et al. (2008) described laryngomalacia as airway obstruction caused by a 
weakened laryngeal framework or arytenoid tissue redundancy in conjunction with 
the Bernoulli effect that, because of the negative pressure within the glottis during 
inspiration, draws the glottic and supraglottic tissues toward the midline resulting in 
vocal fold adduction. Brugman and Simons (1998) described a similar phenomenon 
in which the periglottic structures prolapsed toward the abducted vocal folds at mid-
inspiration, which they called a “functional form of laryngomalacia” (p. 68). Beaty et 
al. (1999) observed exercise-induced laryngomalacia through transnasal flexible 




Heinle et al. (2003), in which seven athletes had laryngomalacia and four others had 
combined PVFM and laryngomalacia.  Richter et al. (2008), described “late-onset 
laryngomalacia” in three teenage female athletes with arytenoid rotation and 
supraarytenoid prolapse into the glottis. They were asymptomatic when not 
exercising. They attributed this condition to tissue redundancy, supraglottic edema, 
and altered laryngeal muscle tone that was further intensified by the Bernoulli effect. 
Thus, exercise-induced laryngomalacia may be the catalyst for vocal fold adduction 
or be a separate laryngeal condition causing air hunger and mimicking PVFM.  
There is evidence supporting subtle laryngeal abnormalities even when the 
person with PVFM is not experiencing dyspnea. Powell et al. (2000) retrospectively 
reviewed laryngoscopic evaluations for 22 asymptomatic patients under the age of 19 
diagnosed with PVFM. Twelve had abnormal vocal fold adduction during “quiet 
respiration” (p. 31). (The authors did not specify in which breathing phase it was 
observed.) Treole, Trudeau, and Forrest (1999) observed the larynx in 50 patients 
diagnosed with PFVM when they were asymptomatic. They observed adduction of 
the vocal folds in all 50 patients during inspiration. The researchers concluded that 
PVFM is a type of laryngeal dystonia because movement abnormalities were 
consistently present in the larynx in varying degrees, yet exacerbated under certain 
conditions.  Newman et al. (1995) also reported the presence of inspiratory closure 
and biphasic closure in 79% of 58 participants who claimed to be asymptomatic at the 
time of laryngoscopy. These reports present convincing evidence that there is subtle 




Respiratory assessment. Respiratory tests are typically the first diagnostic 
procedures performed when individuals present with the complaint of breathing 
difficulty. Balkissoon (2007) suggested that spirometry is best used as a screening 
procedure for PVFM, with actual diagnosis made only following laryngoscopy. The 
test most often reported as being sensitive to PVFM is a flow-volume study that 
generates a graph depicting rate of airflow over respiratory volume while the subject 
performs a maximum inspiration and expiration (Brugman & Simons, 1998). A 
normal flow-volume graph reveals symmetrical curved loops that slope towards the x 
axis for inspiration and expiration, since they are comparable in airflow and volume. 
For individuals symptomatic of PVFM , the inspiratory and expiratory curves lack 
symmetry revealing a flattening (or truncation) of the inspiratory loop indicative of 
reduced airflow into the lungs caused by extra-thoracic obstruction (i.e. narrowing of 
the glottis) (Andrianopoulos et al., 2000; Balkissoon, 2007; Brugman & Simons, 
1998; Heinle et al., 2003;. Mathers-Schmidt, 2001; McFadden & Zawadski, 1996; 
Rundell & Slee, 2008; Sapienza & Hoffman-Ruddy, 2009).  
In a study of 95 patients with PVFM, 25% had truncated flow-volume loops 
during inspiration even when they were asymptomatic at the time of the test 
(Newman et al., 1995).  Koufman and Block (2008) stated that flattening of the 
inspiratory limb of the flow-volume loop “generally rules in PVFM and rules out 
asthma or other lower respiratory diseases” (p. 330). Blunting on the expiratory (in 
addition to inspiratory) curve of the flow-volume loop suggests concurrent asthma or 




There are problems associated with using the aforementioned respiratory test 
for diagnosing PVFM. Most notable is that it is an indirect method of assessing 
laryngeal behavior. The timing of the assessment in relation to symptom onset can 
influence the results particularly if symptoms are present only under non-contrived 
conditions such as the work place or sports field (Rundell & Spiering, 2003). 
Interpretation of the qualitative findings that result from flow-volume loops 
introduces increased subjectivity into the diagnostic process (McFadden & Zawadski, 
1996). 
 Respiratory Resistance. Resistance to airflow may be a useful measurement 
in the assessment of PVFM. Prior research has demonstrated that for most individuals 
without respiratory problems during resting breathing, inspiratory resistance is lower 
than expiratory resistance; this parallels greater vocal fold abduction for inspiration 
than expiration and slight contraction of the lower airways during expiration (Johnson 
et al., 2007). For PVFM, increased inspiratory resistance is expected because of the 
laryngeal constriction occurring most dramatically during inspiration. For individuals 
experiencing biphasic PVFM or PVFM and asthma, increased inspiratory and 
expiratory resistance might be experienced.   
The Airflow Perturbation Device (APD) breathing instrument was developed 
by Johnson, Berlin and Purnell (1974) and further refined by Lausted and Johnson
 
(1999) to provide accurate, near-real-time measures of inspiratory and expiratory 
respiratory resistance (Rr ). Respiratory resistance is defined as the sum of pulmonary 
(airway and lung tissue) and chest wall resistances (Silverman & Johnson, 2005; 




APD to measure resistance in excised sheep lungs at different levels within the 
airway and lungs to determine if the APD measured total airway resistance, 
pulmonary resistance (airway and alveolar resistance), or respiratory resistance 
(pulmonary and chest wall resistance).  A single-subject study conducted by Lausted 
and Johnson (1999) revealed that the perturbations generated by the APD were 
detected by accelerometers adhered to the chest wall indicating its sensitivity to 
changes in chest wall motion. A study that was reported in the same publication 
(Lausted & Johnson, 1999) compared resistance values measured by the APD with 
those measured through whole-body plethysmography, and revealed that although the 
values from the APD were much higher than those obtained through 
plethysmography, the two measures were strongly correlated for all 20 participants.  
The APD works in a manner similar to forced oscillation and flow-interrupter 
techniques (Lausted & Johnson, 1999).  It consists of a pneumotachometer which 
comprises a fine mesh screen with differential pressure ports on either side and a cone 
on one end for attachment of the disposable mouth piece, and modified to include a 
rotating segmented wheel on the opposing end. Pressure transducers on either side of 
the screen determine differential pressure, which is used to determine airflow. The 
rotating wheel perturbs (or periodically slows) the downstream airflow, and is self-
adjusting to be commensurate with changing resistances within the device and the 
respiratory system (Silverman, Johnson, Scott, & Koh, 2005b).  Accurate assessment 
of airflow and air pressure generated by the participant in addition to the resistance 
provided by the device allows for the calculation of Rr (Silverman, et al.2005b). A 




means for inspiratory and expiratory resistances are displayed. APD-measured 
respiratory resistance data were gathered for 900 people ranging in age from 2 to 88 
years, revealing these findings: 1) Rr decreases when comparing the pediatric to the 
adolescent airway; 2) adult men have lower Rr than adult women; and 3) inspiratory 
resistance (Ri) is typically less than expiratory resistance (Re) across the life span  
(Johnson et al., 2007). The first two findings are attributed to differences in airway 
size, and the last finding relates to decreased vocal fold abduction during expiration 
(as contrasted with that during inspiration) for purposes of slowing the exhaled 
airflow, or constricting lower distensible airways during expiration. The current 
model of the APD is compact, hand-held, and yields resistance values consistent with 
the measures obtained with the original desktop APD for calibration and human-
subject measurement comparisons (Silverman et al., 2005a).  
To date, only one published study has been conducted using the APD during 
exercise (Silverman et al., 2005b). Silverman et al. (2005b) measured respiratory 
resistance in 12 male and female non-asthmatic athlete volunteers aged 18 to 40 
years. Their exercise protocol included a period of stretching, warm-up running to 
reach their target heart rate, and 6 minutes of running at 80 to 85% of their maximum 
heart rate. Rr was periodically measured, and when exercise ceased it was 
immediately and continuously measured for 6 minutes.  The results indicated an 
“exercise effect” wherein Ri and Re both decreased following exercise cessation. The 
duration of significant change was 55 seconds for Ri and 35 seconds for Re.  The 
authors attributed this to the body’s need for increased ventilation with decreased 




Provocation challenges. The value of exposing patients to carefully 
controlled conditions that provoke onset of the symptoms has long been recognized 
(Rundell & Slee, 2008). This is especially true for intermittent complaints of dyspnea 
where methacholine challenges differentiate asthma from PVFM (Christopher & 
Morris, 2010; Mathers-Schmidt, 2001; McFadden & Zawadski, 1996; Rundell & 
Slee, 2008). Another essential component of diagnosing PVFM is performing flexible 
or rigid laryngoscopy during or immediately following the provocation challenge 
(exercise, irritant exposure, medication provocation) for purposes of observing and 
documenting changes in laryngeal cartilages and vocal fold motion (Beaty et al., 
1999; Christopher & Morris, 2010;  Gallivan et al.,1996; Gartner-Schmidt (2008); 
Guss & Mirza, 2006; Heinle et al., 2003; Rundell & Slee, 2008;  Rundell & Spiering, 
2003;  Seiner et al., 1987; Tervonen et al., 2009).  
Exercise challenges are used to assess many aspects of cardiac and pulmonary 
health as well as physical fitness (Thompson, Gordon, & Pescatello, 2010) across the 
life span. Procedures and protocols vary depending upon the purpose of the challenge 
(Paridon et al., 2006). The American Heart Association (AHA) has provided 
statements for exercise standards when testing and training pediatric and adult 
patients undergoing exercise challenges with recommendations for equipment, staff, 
procedures and exercise rigor (Fletcher et al., 2001; Paridon et al., 2006). Likewise, 
an 8
th
 edition text published by the American College of Sports Medicine (Thompson 
et al., 2010) provides detailed and comprehensive guidelines for exercise challenges. 
In addition to duration of exercise and criteria for discontinuing exercise, the 




and type of protocol (multistage incremental, progressive incremental, constant work 
rate).  The first two protocols differ by the duration that the exerciser remains at a 
given speed or work load prior to the next incremental increase, whereas for the latter, 
speed and work load remains constant throughout the challenge (Paridon et al. 2006; 
Thompson et al., 2010).   
Most of the patients coming to the Loyola Clinical Centers with symptoms of 
PVFM have previously undergone an exercise challenge conducted by a 
pulmonologist to rule out asthma. Many have participated in a second exercise 
challenge conducted by a cardiologist to rule out cardiac disease. Typically, these 
assessments have followed standardized protocols. That is not the case for diagnosing 
exercise-induced PVFM. Previously published studies where exercise is used to 
trigger PVFM symptoms have lacked consensus in procedure and protocol (Beaty et 
al., 1999; Heinle et al., 2003; Mathers-Schmidt & Brilla, 2005; Tervonen et al., 
2009). Additionally, there have been limited reports of within-patient repeated 
exercise challenge tests to measure PVFM status over time. Thus, there is a need to 
develop a standardized exercise challenge test that can induce symptoms of PVFM 
while meeting AHA’s safety guidelines for exercising pediatric patients. 
Perceptual ratings of dyspnea.  Self-reported ratings of perceived dyspnea 
complement physical measures of exertion, both in everyday activities and during 
provocation challenges.  The Borg Rating of Perceived Exertion Scale ® (Borg, 
1998) seems to be used most frequently in cardiopulmonary and physical fitness 
testing.   It was initially designed to rate perceived exertion (the feelings observed 




exertion). More recently it was modified to include fewer numbers (0 indicating no 
dyspnea and 10 indicating the most severe dyspnea), and to assess more specific 
symptoms such as dyspnea. Prior studies in pulmonary medicine and exercise 
physiology have shown that the scale, when measuring dyspnea, strongly correlates 
with changes in workload (Belman, Brooks, Ross, & Mohsenifar, 1991; Mahler, 
Mefia-Alfaro, Ward, & Baird, 2001).  Fletcher et al. (2001) reported consistency in 
patients’ ratings of perceived exertion using the Borg Scale, suggesting that the scale 
can be used for test-retest purposes. Mahler et al. (2001) found advantages to having 
patients continuously rate their perceived dyspnea using the Borg scale throughout an 
exercise challenge, as opposed to providing a rating at specified intervals (i.e., each 
minute).  Although the two methods (continuous and discrete) were strongly 
correlated, the continuous measurement method was particularly informative when 
patients could only exercise for a few minutes before needing to stop. Mahler et al. 
(2001) recognized the problem of “poor raters,” or individuals whose ratings did not 
coincide with changes in work load. Mathers-Schmidt and Brilla (2005) and 
Hoffman-Ruddy et al. (2004) incorporated the Borg scale into their single subject 
treatments for PVFM. Whereas Mathers-Schmidt and Brilla (2005) used the Borg 
scale and  a second scale for dyspnea ratings, Hoffman-Ruddy et al. (2004) modified 
the scale to ratings of 0 – 5.  It seems that the modified Borg Dyspnea Scale (with 
ratings from 0 – 10) could have clinical and research implications in assessing 




Proposed Research Experiments and Rationale  
A summation of the literature on PVFM contributed by researchers from 
various disciplines reveals emergent understanding of this disorder.  Nevertheless, 
methods and equipment for improving diagnostic accuracy have not been well 
researched.  Misdiagnoses lead to unnecessary medical and pharmacological 
intervention and resource utilization, as well as delayed treatment, impacting the 
physical and psychological health of the sufferer. Many clinicians lack access to the 
instrumentation and personnel needed for laryngoscopic examination. Even those 
who perform laryngoscopy may avoid repeated examinations to follow patients’ 
progress because of the time and cost involved in performing the procedure. To date, 
less invasive objective diagnostic tools for assessing the presence and severity of 
PVFM have been unavailable.   
Respiratory resistance (Rr), especially when separated for inspiratory and 
expiratory phases of the breathing cycle, should be helpful in monitoring and 
quantifying changes within the airway that are caused by changes in the size of the 
laryngeal lumen. If this is the case, the APD may be a promising tool for 
differentiating PVFM from other pathologies involving lower airway obstruction such 
as asthma, and for assessing treatment outcomes. Because of its ease of use, 
noninvasiveness, and portability, it could be an excellent supplement to indirect 
laryngoscopy.  Prior to adopting the APD in clinical practice, however, it is important 
to establish the validity and reliability of the APD for detecting changes in glottal area 
at rest and following exercise for athletes with PVFM (experimental group) and 




Subsequently, the APD can be used to provide outcomes data by which to compare 
athletes with and without PVFM, and to assess changes in Rr presumably owing to 
changes in resistance across the larynx, during exercise. 
This dissertation comprises three studies. The first two are aimed at validating 
the APD for the purpose of assessing airway changes related to PVFM, and are 
foundational for the third study. The third study investigates the effect of exercise on 
Rr in female teen athletes with PVFM and a matched control group of athletes without 
PVFM. A brief description of each study and its associated research question(s) 
follow. 
The Validity Study, (Study 1) investigates the validity of the APD to 
document changes in Rr with concurrent changes in glottal area in order to answer the 
question: How strongly does Rr, as measured with the APD, correlate with glottal 
area? 
The Reliability Study (Study 2) focused on test-retest reliability of Rr in 
athletes with PVFM and athletes without PVFM. The research questions for this 
study are: 1) What is the test-retest reliability for APD-determined measures of Rr 
during resting tidal breathing (RTB) in female teen athletes with PVFM?  2) What is 
the test-retest reliability for APD-determined measures of Rr during RTB in female 
teen athletes without PVFM? 3) What is the test-retest reliability for APD-determined 
measures of Rr during post-exercise breathing (PEB) across three sessions in athletes 
without PVFM?  There are eight dependent variables (DVs) – two of which were 
provided directly by the APD, whereas the rest were calculated from them. Measures 




resistance (Re), and the calculated mean of inspiratory and expiratory resistance (R), 
ratio of inspiratory to expiratory resistance (Ri/Re), change in inspiratory resistance 
(∆Ri), change in expiratory resistance (∆Re), change in mean respiratory resistance 
(∆R), and change in the ratio of inspiratory to expiratory resistance (∆Ri/Re).  Based 
upon the results from the intraclass correlation coefficient analyses, in Study 2, it 
should be apparent which of the DVs are reliable. Once identified, only those salient 
DVs will be investigated in the subsequent studies. 
The Exercise Study (Study 3) investigates the effect of exercise on Rr in 
female teen athletes with and without PVFM. The research questions are: 1) To what 
extent do APD-determined measures of Rr change from RTB to PEB in female teen 
athletes with PVFM?  2) To what extent do APD-determined measures of Rr change 
from RTB to PEB in female teen athletes without PVFM? 3) To what extent do 
measures of Rr change after exercise over a 2-minute course of recovery in teen 
female athletes with PVFM? 4)  To what extent do measures of Rr change after 
exercise over a 2-minute course of recovery in athletes without PVFM? Study 3 also 
investigates differences between the experimental and control groups for Rr, exercise 
duration, and dyspnea ratings from the modified Borg Dyspnea Scale. This research aimed to 
answer the following questions: 1) Do APD-determined measures of Rr during RTB differ 
between female teen athletes with and without PVFM?  2) Do APD-determined 
measures of Rr during PEB differ between female teen athletes with and without 
PVFM?  3) Do athletes without PVFM outperform athletes with PVFM in terms of 




reported at the end of an exercise challenge test differ between female teen athletes 
with PVFM and those without PVFM?   
Each study and its associated background, research questions, results, and 
discussion are presented as a separate chapter in this dissertation. The APD was used 
in all three studies. The participants, equipment, and procedures used for Studies 2 
and 3 are described in Study 2. A general discussion integrating the findings from all 










Chapter 2: Study 1 Validity of APD-Measured Respiratory 
Resistance for Detecting Glottal Change 
 
This study sought to validate the hypothesis that changes in respiratory 
resistance (Rr) measured with the Airflow Perturbation Device (APD), correspond 
with concurrent changes in glottal area (GA). When paradoxical vocal fold motion 
(PVFM) is experienced, the glottis constricts during inspiration because of the medial 
movement of the vocal folds or the prolapse of the arytenoid region into the laryngeal 
airway (Beaty et al., 1999; Christopher & Morris, 2010).  Reduction in GA results in 
greater Rr, which may be further increased by greater airflow turbulence through the 
glottis (Beaty et al., 1999; Ferris, Mead, & Opie, 1963). Patients experiencing 
dyspnea caused by PVFM are often misdiagnosed as having exercise-induced asthma 
(Brugman & Simons, 1998; Christopher et al., 1983; Mathers-Schmidt, 2001; 
Newman et al., 1995). Unlike PVFM, asthma causes constriction in the bronchi and 
bronchioles; therefore, it affects the expiratory phase of the breathing cycle more than 
the inspiratory phase (Brugman & Simons, 1998; Collett, Brancatisano & Engel, 
1983; Hurbis & Schild, 1991). Despite both PVFM and asthma being associated with 
increases in Rr, their effects on inspiratory and expiratory phases differ, which helps 
differentiate them in diagnosis. 
Rr measured by the APD is the sum of pulmonary (airways and lung tissue) 
(Johnson & Sahota, 2004) and chest wall resistances (Lausted & Johnson, 1999). It 
provides separate reports for inspiratory and expiratory resistances (Ri and Re, 




APD for research in patients with PVFM, it is essential to examine whether APD-
measured Rr is sensitive enough to detect changes in the laryngeal airway when 
significant laryngeal constriction occurs. To validate the instrumentation needed for 
the series of studies to follow, the following question was posed: Does Rr measured 
by the APD strongly correlate with GA as measured from a two-dimensional aerial 
view of the larynx?  
It was hypothesized that laryngeal constriction can be detected and quantified 
by Rr measured by the APD. To mimic PVFM, the laryngeal airway was volitionally 
constricted during inspiration. The specific hypothesis was that GA and Rr are 
inversely related.  
Method 
Participant 
A healthy 55-year-old female (the investigator) with normal respiratory and 
laryngeal function participated in this study that took place at Greater Baltimore 
Medical Center (GBMC).  A laryngologist at Loyola University Maryland (LUM) 
confirmed normal laryngeal structure and function in the participant through rigid 
laryngoscopy. Respiratory function was validated by an allergy and asthma physician 
through pulmonary function tests, which included forced vital capacity, forced 
inspiratory and expiratory volume in one second, and peak inspiratory and expiratory 
flow. Results from the pulmonary function tests were within normal limits for the 
participant’s age and sex.  
Instrumentation and Materials  
 Laryngoscope. Laryngoscopy was conducted with a digital chip flexible 




Stroboscopy System, (Model 9200C, KayPentax, Montvale, NJ), that digitally 
recorded and stored the laryngeal examination to a workstation for playback and 
analysis. During the examination, the laryngoscope operator (a speech-language 
pathologist) who was trained and experienced in performing the procedure, observed 
the laryngeal changes in real time on a LCD monitor.  
Airflow Perturbation Device. The APD (Figure 1) is a hand-held unit with a 
rotating wheel that perturbs air flow and calculates Rr for each perturbation in near-
real time based upon changes in airflow rate and air pressure. It operates on 
alternating electric current and transfers data to a laptop computer installed with 
custom software that constantly monitors and records Rr in cmH2O/L/s during 
inspiration and expiration for each perturbation. Prior to use, the instrument self-
calibrates when it is turned on and is recognized by the computer.  During data 
collection, after the first 5 seconds of breathing, Rr is recorded in 1-minute trials into 
a Microsoft Excel spreadsheet. Specifically, for each trial (a continuous 1-minute 
recording of Rr), the following data are recorded in separate columns: sequence of 
perturbations during inspiration and expiration, respectively; time of each 
perturbation (displayed to the nearest millisecond); air pressure (in cmH2O) for each 
perturbation; airflow (in L/s) for each perturbation; and Rr (pressure/flow, in 
cmH2O/L/s). Ri and Re displayed on the computer following each trial are the mean of 
all perturbations during inspiration (Ri) and during expiration (Re), respectively. In 
Study 1, Rr for each perturbation was used in the analysis although the means of Ri 




between rest and feigned PVFM breathing as well as between Ri and Re. In 
subsequent studies, the means of Ri and Re in the same trial were used.  
             
Figure 1. Cut away diagram of the Airflow Perturbation Device (left) (reprinted with 
permission from Lausted & Johnson, 1999), and an athlete using the APD (right) 
(reprinted with permission by the athlete).  
 
Glottal area analysis. Glottal area analysis was conducted with Kay’s Image 
Processing System (KIPS), software produced by KayPENTAX (Montvale, NJ) that 
comes standard with the purchase of their High-Speed Video System (Model 9710). 
 Procedure 
On the day of the study, the participant practiced simulating breathing that is 
characteristic of PVFM and visually monitored her vocal folds during inspiration and 
expiration using laryngoscopy at the Loyola Clinical Center in Columbia. The goal 
was to narrow the glottis during inspiration. Likewise, the participant practiced both 
comfortable resting breathing and simulated PVFM breathing with the APD in 
advance of data collection to ensure proper imitation. Data collection for the study 




Prior to laryngoscopy, the participant performed two1-minute trials of normal 
resting tidal breathing (RTB) with the APD to gather baseline Rr data. In preparation 
for the laryngoscopy procedure, the nasal mucosa was anesthetized with a cotton 
swab saturated with a 4% Xylocaine solution. Three minutes later, the SLP passed the 
flexible laryngoscope transnasally and simultaneously viewed the larynx on a 
monitor.  Maintaining a consistent distance between the distal tip of the endoscope 
and the glottis was attempted.  With the scope in position, the participant inserted the 
APD mouthpiece while maintaining a tight lip seal throughout the experiment 
(Lopresti et al., 2008). Throughout the experiment, the participant wore a nose clip 
that prevented transnasal breathing. The participant held the APD in one hand, firmly 
pressing her cheeks with her other hand. Another SLP viewed both the monitor and 
computer screen, while operating the computer and giving instructions. The 
participant then simulated laryngeal function characteristic of PVFM for a 1-minute 
trial. Following this, the scope, APD mouthpiece, and nose clip were removed.  The 
laryngeal imaging digital file and the Rr data file were saved and electronically copied 
for future analysis.  
Data Analysis 
Laryngeal imaging. Sixteen continuous breathing cycles were available for 
analysis. Narrowing of the glottis as a result of vocal fold adduction signaled 
inspiration, whereas glottal widening via vocal fold abduction signaled expiration. 
Identifying the beginning and ending of each cycle was also aided by the vertical 




breathing. Figure 2 illustrates extreme vocal fold approximation during inspiration 
and vocal fold separation during expiration of feigned PVFM in this study. 
 
  
Figure 2. Maximal constriction of the laryngeal airway during inspiration (left) and 
minimal constriction during expiration (right) during feigned PVFM-type breathing. 
 
 Video frame numbers at the start of each inspiratory and expiratory phase 
were noted.  From the 16 breathing cycles being video-recorded, seven were chosen 
for frame-by-frame GA analysis. These included breathing cycles 6-9 and cycles 14-
16. The remaining data could not be analyzed for at least one of the following 
reasons: a) fogging of the endoscopic image, b) medial displacement of the arytenoid 
cartilages during inspiration that obscured the view of the glottis, and c) 
indeterminate moments of inspiratory and expiratory onset and offset (Cycle 11).  
After converting the video file into AVI (Audio/Video Interleaved) format at a 
rate of 30 frames per second, KIPS software was used to segment and measure GA. 
This was accomplished by creating a montage of multiple frames, detecting glottal 




folds. A GA waveform (extracted from the analysis of a sequence of glottal images) 
is generated with frame number on the abscissa and GA (measured in square pixels) 
on the ordinate (Figure 3).  Results of the maximum GA for the corresponding video 
frame are saved in a numerical report. The onset of each inspiratory phase was 
identified as the first frame when adductory motion of the vocal folds occurred. 
Inspiration continues until the first frame when abductory motion began which 
signaled the beginning of expiration. The GA analysis included breathing cycles 6, 7, 
and 8, beginning on frame 1102 and ending on frame 1443, for a total of 341 frames.  
 
 
 Figure 3. Glottal area (GA) montage (left) illustrating vocal fold opening, closing 
and closed phases, and GA waveform (right) with video frame number on the x axis 
and glottal area measured in square pixels on the y axis from KayPENTAX’s Image 





Respiratory Resistance. Using data from the second APD trial that 
corresponded to the laryngeal recording, Ri and Re for each perturbation were 
identified for all 16 breathing cycles and graphed in a spreadsheet program (Microsoft 
Excel, 2007). Each data point identified a particular moment of perturbation and the 
corresponding resistance value. From this, the beginning and ending points of every 
inspiration and expiration were identified on the graph. As in the video recording 
described above, Cycle 11 was noted to be aberrant in duration and resistance values. 
For this reason, cycles 6, 7, and 8 were chosen for analysis. The first inspiratory 
perturbation of Cycle 6 began at 18.52 seconds and the last expiratory perturbation 
for Cycle 8 occurred at 29.77 seconds. By converting the perturbation time segments 
to frames (time multiplied by 30) and rounding to the nearest whole number, 
breathing cycles 6-8 encompassed 337 frames. A comparison of number of frames in 
the analysis revealed 4 more frames in the glottal analysis than in the respiratory 
resistance analysis, a difference of 0.133 seconds. This discrepancy can be explained 
by the error introduced by Rr that has a lower sampling rate (in this sample, a 
perturbation occurred approximately every 0.118 seconds on average) than GA 
(measured every 0.033 seconds). Thus, the error was equivalent to approximately one 
perturbation. 
Video images were synchronized to the breathing cycles by first matching 
Cycle 3. This cycle was synchronized by the examiner’s verbal prompt “Okay,” a 
robust inspiration from the video recording, and an obvious increase in Ri in the APD 
signal. From that moment, the frames corresponding to the onset and offset of each 




(Frame 1102) was matched with the time segment for the first inspiratory perturbation 
(18.52 seconds) for the same cycle.  The graph created from the Rr during all 
perturbations is pictured in Figure 4. The three cycles selected for analysis are 
indicated by arrows. Also labeled are Cycles 3 and 11 as previously described.   
 
Figure 4. Breathing cycles generated from respiratory resistance (Rr) values with 
three cycles selected for analysis. 
 
Rr and GA were compared directly by aligning the two waveforms for visual 
inspection. Associations between the two variables were evaluated with cross-
correlation analysis performed in SPSS version 18, to compare the variables while 
accounting for time. 
Results 
Respiratory Resistance  
To ensure that the participant’s breathing when feigning PVFM differed from 
her normal breathing, two trials of normal resting tidal breathing (RTB) were 
performed using the APD. The mean Ri and Re during RTB were compared to results 




during RTB and feigned PVFM breathing in all 16 breathing cycles, and in Cycles 6-
8 (the cycles selected for correlation analysis between Rr and GA).  
 
Table 1 
Inspiratory and Expiratory Resistance during Resting Tidal Breathing (RTB) and 
feigned Paradoxical Vocal Fold Motion (PVFM) Breathing 




RTB 2.37 2.61 
PVFM  Breathing   
              Cycles 1-16 8.01 3.30 
              Cycle 6 8.58 3.11 
              Cycle 7 8.80 3.85 
              Cycle 8 8.67 5.26 
 
  During RTB, Ri values were lower than those for Re, with a ratio of 0.91, 
indicating perhaps, in part, greater vocal fold abduction during inspiration than during 
expiration. When feigning breathing like that of PVFM, it is clear that the greatest 
deviation from RTB occurred during inspiration. Ri in cycles 6-8 were quite 
comparable to each other yet slightly higher than the average Ri across all 16 cycles. 
Re in cycles 6 and 7 were comparable to each other and to the overall PVFM average. 
Cycle 8, on the other hand, differed by 59% when compared to Re averaged across all 
16 cycles. A drastic difference was seen between Ri during RTB when compared to 
PVFM breathing (238% increase). The difference between Ri and Re also increased 





Glottal Area and Respiratory Resistance  
GA and Rr were synchronized and graphed for breathing cycles 6-8 (Figure 
5). The initial scatterplot of Rr over GA suggests a semi-logarithmic correlation 
between the two variables; therefore, log10 (GA) is used in subsequent graphs. When 
observing Rr, higher values (i.e., peaks) are associated with inspiration, and lower 
values (i.e., valleys) with expiration. GA, in contrast, is larger during expiration and 
smaller during inspiration. In addition to their changes in the opposite directions 
during breathing, the data in Figure 5 show that Rr and GA exhibit similar periodicity 
— both parameters undergo three complete cycles during the 11.25 seconds of 
recording.  
 
Figure 5. Rr (grey) and log10(GA) (black) waveforms for PVFM breathing cycles 6-8 
 
The scatter plot in Figure 6 shows the relationship between Rr and log 
transform of GA obtained from cycles 6-8. The log transform of GA reduced the 
large spread in GA pixel values ranging from 81 to 11,448 square pixels during three 





Figure 6. Respiratory resistance (Rr) and log-transformed glottal area [log10(GA)] for 
three complete breathing cycles (6-8) shown in Figure 5. The linear trend line shows 
that Rr gradually increases as GA decreases.    
 
   To explore the time-locked relationship between Rr and GA, cross-correlation 
analysis was conducted to determine a potential time delay between Rr and GA, as 
well as the magnitude of the correlation. The cross-correlation coefficient (CCC) was 
computed between 20 future and 20 previous values of Rr for each GA data point. 
This window of preceding and subsequent data points (i.e., lags) can accommodate 
delays between the two signals of more than one breathing cycle since each complete 
cycle comprises roughly 30 consecutive data points. The result of this analysis is a 
vector of non-differenced cross correlation function values computed between Rr 
and GA for each positive and negative lag position. The graph of the correlation 
(Figure 7) illustrates the same periodicity that was observed in the Rr and GA graphed 






Figure 7. Cross correlation coefficients (CCC) for Rr and GA plotted against lag 
position. Confidence limits mark 2 standard errors at each lag position.  
 
The computed CCCs for each of the 20 forward and backward lag positions 
show that the largest CCC occurs at a lag position of +2.  A CCC of -0.824 shows 
that there is a strong and negative linear relationship between changes in GA and 
changes in Rr (i.e., an increase in GA leads to a reduction in Rr). The lag position of 
+2 indicates that the cyclic changes in GA occur approximately two data points (0.2 
s) ahead of the measured Rr and confirm that both parameters are nearly 
synchronized. The time delay is calculated based upon a perturbation data point 






The hypothesized inverse relationship between GA and Rr during feigned 
PVFM breathing is supported by the results reported herein. The cross-correlation 
analysis revealed a strong negative correlation between GA and Rr with a lag of 
approximately 0.2s between GA and Rr . This reveals that Rr decreases when GA 
increases, and that changes in GA precede changes in Rr. Although it is logical that 
the change in GA occurs first, the lag time was somewhat greater than expected.  
 There are two possible explanations for the slight asynchrony between GA 
and Rr. First, the onsets of inspiration and expiration were marked by the first 
observed video frame signaling vocal fold adduction and abduction, respectively. 
Thus, human error may have contributed to a misidentification of each breathing 
phase within a few video frames. Also, synchrony of GA and Rr may have been 
impacted by a time delay between the beginning of vocal fold movement and the 
measurement of air pressure and flow change by the APD (A. T. Johnson, personal 
communication, October 11, 2011). A change in airflow sensed at the mouth opening 
is not recorded by the device until the next perturbation. This delay can be as great as 
100 ms, which is equivalent to the average period between adjacent perturbations. 
Overall, however, the lag between the data signals was small and was accounted for 
in the calculation of the cross correlation coefficient. 
This is the first known attempt to correlate Rr, measured with the APD, with 
GA, and as such presented challenges. The authenticity of this study would be 
improved if it was performed during exercise with a participant diagnosed with 




not easily accommodate performing exercise, which would have been required to 
induce PVFM signs. Likewise, the intermittent nature of PVFM cannot guarantee the 
desired response. To ensure observable data that would illustrate the issue at hand, a 
normal and well-informed adult feigned breathing typical of PVFM while seated. The 
participant purposely over-exaggerated glottal constriction during inspiration so that 
the two phases of the respiratory cycle were distinctly different. This amount of 
glottal constriction sometimes interfered with clear visualization of the laryngeal 
airway that was required for GA analysis, thus limiting the number of cycles available 
for analysis.  
Additional challenges for this study and proposed solutions include the 
following: (1) Synchronizing the laryngeal recording with the start of the APD trial. 
This could have been remedied with an external beep tone. (2) Identifying the 
beginning and ending of each breathing phase from the laryngeal images. This could 
have been solved by using respiratory inductance plethysmography simultaneously 
with laryngoscopy and the APD to clearly define breathing phases. (3) Controlling for 
the distance between the tip of the scope to the vocal folds. This could have been 
facilitated by marking the place on the scope where it entered the nose in order to 
keep a constant distance. However, the natural descent of the larynx during 
inspiration would vary this distance. (4) Finally, analyzing more breathing cycles than 
what was done for this study would inevitably provide a better understanding of the 







This preliminary study supports the hypothesis that Rr assessed with the APD 
is negatively correlated with changes that occur at the vocal folds in a single 
participant volitionally producing glottal constriction during the inspiratory phase of 
breathing. Study 2 will investigate test-retest reliability of the Rr measurements in 





Chapter 3: Study 2 Test-Retest Reliability of Respiratory 
Resistance Measured with the APD 
Findings from Study 1 revealed that there was a strong negative correlation 
between respiratory resistance (Rr) as measured with the Airflow Perturbation Device 
(APD) and glottal area (GA). This suggests that Rr measures may be a non-invasive 
alternative to laryngoscopy in diagnosis and outcome assessment for PVFM. To 
further investigate whether Rr can be adopted for clinical and research use in 
individuals with PVFM and healthy controls, its reliability has to be established. 
Likewise, generating reliable results with the measurement protocol including an 
exercise challenge to elicit changes in Rr should be proven.  
The purpose of this study is to determine if Rr measures are reproducible 
across trials within the same session (short-term reliability) and across sessions (long-
term reliability) during resting tidal breathing (RTB) and post-exercise breathing 
(PEB). RTB is tested during three consecutive 1-minute breathing trials conducted 
before exercise begins, whereas PEB is assessed from three consecutive 1-minute 
breathing trials conducted immediately after exercise ends.  
Strong within-subject test-retest reliability is desired during RTB, for both 
short- (intrasession) and long-term (intersession) comparisons. Likewise, Rr during 
PEB should show strong within-subject test-retest reliability when trials of the same 
order are compared across sessions (i.e., Rr in PEB trial 1 during session 1 should be 




Lausted and Johnson (1999) tested reliability of Rr measured by the APD 
during RTB. The researchers used the grand mean (Rr) of inspiratory (Ri) and 
expiratory (Re) resistance as their dependent variable rather than parceling Ri and Re. 
Rr was measured in four participants for five trials occurring across 15 minutes on the 
same day, in six participants for one trial per day over three consecutive days, and in 
seven participants for one trial per week over three consecutive weeks. Their results 
showed that reliability was strongest when one measure was taken per day for three 
days yielding a coefficient of variation (CV) of 1.8%, followed closely by multiple 
measures during the same day, with a coefficient of variation < 4% (an exact CV was 
not provided). The greatest variation was observed when resistance was measured 
once per week for three weeks, yielding a CV of 7.2%. They concluded that test-
retest reliability overall was strong. This study, however, used small sample sizes and 
lacked clarity regarding whether the same participants were used for each test session 
since numbers of participants varied from four (study 1) to seven (study 3). In 
addition, Rr was measured during RTB only, and there was no exercise component 
included in the study.  
In another experiment, Silverman et al. (2005) investigated changes in Ri and 
Re following exercise in 12 adult athletes using the APD, to determine if an exercise 
effect could be detected and if so, to quantify the duration of the exercise effect. Their 
exercise protocol followed this sequence: a 5-minute treadmill warm-up at 50-60% 
maximum heart rate (HRmax); 5-minute stretching; a moderate-exercise period where 
treadmill speed and incline were increased in 3-minute increments until achieving 80-




was first recorded during RTB prior to exercise. It was recorded again following the 
stretching portion and finally for six consecutive minutes immediately after the 
moderate exercise portion. A comparison of pre- to post-exercise results 
demonstrated a significant decrease of Ri following exercise that lasted for 55 
seconds, while a concomitant decrease in Re occurred within the first 35 seconds 
following exercise.  After these intervals, both resistance measures progressively 
returned to pre-exercise baseline levels. This is the first exercise study in which the 
APD was used, and as such provided insight regarding the methodology for the 
present study. Measuring Rr prior to and following the warm-up and stretch portions 
of the exercise protocol (Silverman et al., 2005) did not appear to provide useful data, 
and may have negatively impacted the athletes’ performance for the moderate-
exercise portion (for which the researchers were most interested). The researchers 
used an exercise program where speed and incline were adjusted at 3-minute intervals 
that may have created uneven changes in physiological response to exercise and 
overestimated exercise capacity (Thompson et al., 2010, p. 112). The researchers 
reported that it required 5 seconds for the athlete to transfer from the treadmill to the 
APD, and typically 30 seconds for APD measurement to begin, suggesting that they 
lost at least 35 seconds of post-exercise breathing assessment. Finally, statistical 
significance was based upon multiple related-samples t-tests with no reported control 
for Type I error. Nevertheless, this study demonstrated that the APD could handle 
high airflow rates associated with exercise and could capture an exercise effect that 
differed between Ri and Re. These two studies (Lausted & Johnson, 1999; Silverman 




demonstrated that significant changes of Rr following exercise could be detected by 
the APD. 
The present investigation was designed to measure Rr within and across 
sessions in healthy female athletes for three sessions during RTB and PEB following 
a customized exercise protocol. There were three consecutive trials in each session. 
The study also tested cross-trial reliability of Rr in athletes with PVFM during RTB, 
taken at the beginning of an initial evaluation session only. The decision for them to 
participate in only one exercise challenge test before receiving any treatment was 
deliberate. Prior to the athletes with PVFM coming to Loyola Clinical Centers (LCC) 
for an evaluation by the SLP, they had undergone at least one diagnostic exercise 
challenge by the pulmonologist, and often more diagnostic exercise challenges by an 
otolaryngologist and/or a cardiologist because the differential diagnosis for PVFM is 
often challenging and interdisciplinary. By the time the athletes came to LCC, they 
were usually very anxious to get a definitive diagnosis and begin treatment. While 
baseline data from repeated exercise challenge tests for these athletes can help to 
determine test-retest reliability, it seemed unethical to delay treatment so that another 
exercise challenge can be conducted. Also, potential psychological consequences of 
repeated testing prior to treatment may have a negative impact on the success of 
treatment.    
For the purposes of this dissertation research, the reliability of Rr measured by 
the APD needed to be evaluated with repeated measures on the same group of athletes 
following a consistent exercise protocol that was appropriate to elicit PVFM 




reliability for Rr measured by the APD during resting tidal breathing for female teen 
athletes without PVFM? 2) What is the test-retest reliability for Rr measured by the 
APD during post-exercise breathing across three sessions for female teen athletes 
without PVFM?  3) What is the test-retest reliability for Rr measured by the APD 
during resting tidal breathing for female teen athletes with PVFM?   
There are eight dependent variables for this study. Two are reported directly 
by the APD: inspiratory resistance (Ri) and expiratory resistance (Re). Six others are 
calculated from Ri and Re: the mean of Ri and Re (Rr), ratio of inspiratory to 
expiratory resistance (Ri/Re), change in inspiratory resistance (∆Ri), change in 
expiratory resistance (∆Re), change in mean Rr (∆Rr), and change in the ratio of 
inspiratory to expiratory resistance (∆Ri/Re) (the latter four measured in percent).  
This study aimed to assess reliability of all eight variables, described in detail in the 
following paragraphs. Only the variables with high reliability would be selected for 
the subsequent studies in this project. It was hypothesized that Ri, Re, Rr, and Ri/Re 
during RTB in both athlete groups would show strong reliability within the same 
session based upon the findings of Lausted and Johnson (1999). Between sessions, 
reliability can be influenced by internal validity threats, particularly maturation 
(physical health and athletic condition of the individual at the time of testing), test-
retest difference (reduced or increased anxiety with each subsequent session), and 
procedures (instructions given, use of the APD). Based upon the findings of Lausted 
and Johnson (1999), greater variability was expected across sessions compared with 
that across trials within the same session.  For this reason, it was deemed important to 




exercise measures since it may be a more consistent variable for intersession 
comparisons (Johnson et al., 2007).  
Decreased intersession reliability was anticipated during PEB as compared 
with that during RTB because exercise can invoke threats to internal and external 
validity. Performance during each exercise challenge can vary because of fluctuations 
within the respiratory system in general. Similarly, variations in exercise duration for 
each session and across athletes can be expected. Increased familiarity with the 
exercise protocol may change performance as well. Nevertheless, the direction of 
change in Rr measures should be consistent as the respiratory system responds to the 







trial) are hypothesized to be reliable across three sessions in the control athlete group. 
The intra-session cross-trial test-retest reliability during PEB was not of interest in 
this particular study because the previous study by Silverman et al. (2005) showed 
that the exercise effect on Rr was transitory.  Consequently, Rr varied significantly as 
the respiratory system recovered to its baseline level following exercise.  Thus, while 
reliability is expected for intra-session measures during RTB, changes across trials for 
PEB are expected because of the possible effect of exercise on the respiratory system. 
The final study in this project will investigate how exercise influences Rr measures in 
athletes with and without PVFM.    
Methods 
Participants 
Twelve female teen athletes with PVFM composed the experimental group 




Inclusion criteria for all participants (summarized in Table 2) included: female, ages 
12-19 yr, participation in at least two seasons per year of aerobic sports, and 
willingness to run on a treadmill. Only females were selected for this study because 
there is a much higher incidence of PVFM in females (Hicks et al., 2008; Patel et al., 
2004; Powell et al., 2000). Exclusion criteria included: a concurrent diagnosis of 
asthma, or a history of cardiac problems, joint or back pain, or shin splints. All races 
and ethnicities were eligible to participate. All but two participants in each group self-
reported to be Caucasian. Two of the athletes in the experimental group self-reported 
to be Hispanic-Caucasian and two (sisters) in the control group claimed to be part 
Native Asian Islanders. Table 3 describes age, height and weight for both athlete 
groups.  
Each athlete in the experimental group received the diagnosis of PVFM by 
their referring otolaryngologist or pulmonologist prior to or at the time of their first 
appointment at LCC by the consulting otolaryngologist. If diagnosis was not 
confirmed with a laryngoscopic examination, this was conducted during the first 
appointment at the LCC. Candidates qualified to be in the experimental group if they 
demonstrated glottal constriction during inspiration after an exercise challenge, as 
described below under recruitment procedures. Participants in the control group were 
excluded if they answered positively to the list of symptoms suggestive of PVFM or 
asthma (See Appendix A for the Control Athlete Questionnaire).  
All participants or their parents provided informed consent or assent in 
accordance with the rules and regulations of the Institutional Review Board at Loyola 




which they participated. Experimental participants did not receive financial 
compensation, but they were provided a complete diagnostic evaluation of PVFM and 
treatment recommendations by the investigator, a speech-language pathologist (SLP) 
who specializes in this disorder.  
Table 2  
Inclusion and Exclusion Criteria for Experimental and Control Athletes 
 PVFM Athletes  Control Athletes 
Inclusion Criteria Exclusion  Criteria Inclusion Criteria Exclusion Criteria 










≥ 2 sport seasons/yr Back or joint pain  ≥ 2 sport 
seasons/yr 
Back or joint pain  
 
Diagnosis of PVFM 
from referring 
physician 
       or 
Laryngoscopic 










PVFM or asthma 
 
Table 3 
Descriptive Statistics for Age, Height, and Weight for the Experimental and Control 
Athletes                                      
    PVFM Athletes            Control Athletes 





14.8     (1.6) 
 
      12 - 19 
 
  14.5         (1.4) 
 
     12 – 17 
Height (cm) 
 
160.5   (6.4) 
 










 Treadmill. The exercise task was carried out on a commercial grade treadmill 
(Nautilus NTR700) that allows changes in speed and incline. The displayed items of 
interest include speed, incline, and time. There are two controls that stop the 
treadmill, one being a red lever that immediately stops the treadmill and that is easily 
accessible to the runner as well as the research personnel monitoring the exercise 
challenge, and the other being the power button. Prior to each exercise challenge, the 
treadmill was calibrated with its automatic calibration feature. When this feature is 
activated, the treadmill cycles through all of its speed and incline settings, and 
displays on the treadmill monitor that calibration has been successful. In all instances 
of treadmill calibration throughout this research, the calibration standards were met. 
Between uses, the treadmill hand-railings and control panel were carefully cleaned 
with a hospital-grade antibacterial wipe. 
 Heart rate monitor.  Heart rate was monitored continuously prior to, during, 
and following the exercise challenge using a Polar FS2C heart rate monitor (Polar 
Electro Inc., Lake Success, NY). The heart rate monitor comprises a transmitter with 
two surface electrodes that detect the heart beat and transmit it to a wrist watch unit. 
The transmitter is held in place by its connection to an elastic strap that goes around 
the chest below the breasts. The wrist unit displays heart rate and exercise time. Once 
the heart rate monitor is activated, it requires 15 seconds to begin displaying heart 
rate. The wrist unit picks up the transmitted signal within 3 feet of the transmitter, 
thus allowing the investigator to hold the unit or attach it to the treadmill while the 




of diseases, every participant had her own elastic strap that was labeled, laundered 
between appointments (for the control athletes), and stored in a zip-lock bag 
according to her participant number. The transmitter was wiped with a hospital-grade 
antibacterial wipe between uses, per the instruction of a representative of the Polar 
Company (email communication, February 18, 2010).  
Airflow Perturbation Device (APD). The APD was used to assess 
respiratory resistance in this study.  Details regarding this device are provided in 
Chapter 2.  
Facilities and Personnel  
 Test and observation rooms. All evaluation sessions were conducted at LCC 
Columbia campus. The test room had an adjoining private room where parents could 
observe the diagnostic sessions. When parents observed, a Loyola University SLP 
graduate student was present to answer questions and relay pertinent information to 
the investigator. The participant was always informed that her parent would be 
observing from the adjoining room.  
The equipment in the test room included a table and several chairs, a 
treadmill, and an APD connected to a laptop computer. Additionally, an 
otolaryngology examination chair and laryngoscopy equipment were housed in this 
room. The room was also equipped with a telephone, portable oxygen supply, and 
ammonia inhalants. Fortunately, there were no accidents or other adverse events 
during implementation of this research project. 
Graduate SLP student assistants. The investigator (also a clinical 




academic semester. The investigator provided extensive training to the graduate 
students regarding their involvement of this research which was repeated each 
semester until the completion of the study.  The graduate students practiced 
interviewing and assisting with exercise challenges prior to any interaction with the 
experimental or control participants. The investigator was present in the test room for 
every exercise challenge.  
All graduate students as well as the investigator were certified in adult and 
child cardiopulmonary resuscitation (CPR) and use of the automated external 
defibrillator (AED).  
Procedure 
Recruitment of athletes with PVFM. The participants with PVFM were 
referred to LCC by local pulmonologists, immunologists (asthma and allergy 
physicians), otolaryngologists, cardiologists, and pediatricians. In all cases, the 
diagnosis of PVFM was suspected, but few patients had undergone laryngoscopy to 
confirm the diagnosis of PVFM. Thus, most patients coming to LCC needed a 
definitive diagnosis of PVFM. The diagnosis was made by reviewing previous 
medical findings, listening to their symptom description, and then examining their 
larynx and vocal folds prior to and immediately following an exercise challenge test.  
Laryngeal examination was conducted by the investigator, who holds the ASHA 
Certificate of Clinical Competence, in accordance with the guidelines determined by 
the American Speech-Language-Hearing Association (American Speech-Language 
Hearing Association, 1998, 2004a, 2004b) and the Maryland Board of Examiners for 




performed by a consulting otolaryngologist to LCC. ASHA mandates that all 
laryngeal imaging studies be reviewed by a qualified medical doctor who makes the 
diagnosis.     
Recruitment of control athletes. Female athletes were recruited from middle 
and high schools in the local area by contacting school personnel. They were 
informed that the control athletes would receive compensation of $20.00 for their 
participation in each session. 
Screening of athletes with PVFM. The PVFM diagnostic questionnaire 
(Appendix B) that is used routinely at LCC for all diagnostic evaluations served as 
one method for determining candidacy for the study. Of particular interest were 
answers to these questions: personal information (age); sports information (type of 
sport, level of play, seasons per year for athletic involvement); medical diagnoses 
(conditions and medications taken); psychological diagnoses (conditions and 
medications); PVFM ratings (symptom severity, frequency and sense of control). The 
participants also rated their general overall health on the day that the questionnaire 
was completed to alert the interviewer of possible illness. Race and ethnicity, 
although voluntary information, was provided by all participants. Information from 
the diagnostic questionnaire supplemented the case history form completed by the 
parent as part of the clinical record at LCC.   
Athletes were invited to participate in the study if their answers to the 
screening questions met the study criteria, and if evidence of PVFM (medial 
movement of the true vocal folds and/or prolapse of the corniculate and arytenoid 




their parent) received education about the purposes of the study and the time 
commitment. Written informed consent and assent for parents and participants 
(respectively) were granted. One 19-year-old athlete self-consented.  All participants 
were assigned a seven-digit medical record number that served as their research 
identification number. 
Screening of control athletes. For athletes without diagnosed asthma or 
PVFM who expressed an interest in participating, the investigator communicated with 
their parent(s) explaining the study, answering questions, and seeking written 
informed consent and assent. The control group questionnaire asks similar sport and 
health-related questions as the one for athletes with PVFM, yet also queries possible 
symptoms associated with undiagnosed PVFM or asthma. These symptoms include: 
dyspnea (breathing difficulty), feelings of throat tightness or closure, stridor, 
hyperventilation, chest tightness, and wheezing. 
Over the course of the research, five athletes came to the clinic and answered 
positively to symptoms suggestive of PVFM or asthma, or disclosed that they had 
used an inhaler within three months prior to coming to LCC. Although none of the 
five had a confirmed diagnosis of PVFM or asthma, they were excluded from the 
study. The data for another control athlete (attending all three sessions) were 
excluded because her PVFM counterpart, after attending the session, retrospectively 
withdrew from the study.   
Experimental Procedures  
Pre-exercise interview of athletes with PVFM. A graduate student clinician 




escorted her to the test room where an explanation of the components of the session 
was given in the order that that each would occur. Laminated pictures of a female 
teen athlete using the APD, running on the treadmill, and receiving a stroboscopic 
examination of her larynx were shown to the participant. Then through interview 
format, the participant answered questions about her symptom severity, frequency, 
feelings of control, medical and psychosocial history.  The athletes’ answers were 
validated by her parent, who was in the observation room, or from the case history 
completed by the parent prior to the appointment.  
Pre-exercise interview of control athletes. The control athletes followed the 
same procedures as those with PVFM for the pre-exercise portion. The screening 
questionnaire that was administered during the first session was reviewed with the 
control athletes prior to each of the subsequent two sessions to document changes that 
may have occurred. Attempts were made to schedule each of the three sessions 
biweekly. Because the athletes were involved in school, sports, and other activities 
and had to travel to LCC, they attended each session as their schedule allowed. The 
interval between sessions averaged 40 days, but ranged from same day to 343 days.  
Exercise challenge test for all athletes. The exercise challenge began 
following the interview using a treadmill, a heart-rate monitor, and an APD. Severity 
of breathlessness was continuously rated using the modified Borg Dyspnea Scale. The 
protocol for the exercise challenge integrated aspects from previously published 
protocols (Fletcher et al., 2001; Paridon et al., 2006; Thompson et al., 2010), and 




Instruction for using the heart-rate monitor. The investigator explained the 
purpose of the heart-rate monitor and instructed correct placement of the sensor band 
and strap. The athlete was shown to the restroom where she put on the band 
unassisted. When the athlete returned to the room from putting on the band, the 
researcher activated the heart-rate monitor, and ensured that it was functioning 
correctly.  Maximum heart rate for females within the 12 – 19 year old range was 
calculated using the formula: HRmax= 207 – (0.07 x age) (Gellish et al. 2007), posted 
on a white board and noted on the participant’s exercise challenge data sheet. Heart 
rate was monitored and recorded prior to and following exercise, and at 1-minute 
intervals throughout exercise.    
Instruction for using the Modified Borg Dyspnea Scale. Instruction was 
provided about the modified Borg Dyspnea Scale (Borg, 1998) used to query severity 
of breathlessness prior to, during and following exercise. The investigator described 
the term dyspnea as “difficulty breathing” or “a feeling of breathlessness.” The scale 
begins at 0 (“nothing at all”), progresses to 0.5 (“very, very slight”), and continues 
with whole number ratings through 10 (“maximal severity”), having a total of 11 
increments. This scale was chosen because it has been validated and confirmed 
reliable by published studies, and is popular in pulmonary medicine and sports 
medicine (Elliott et al., 1991; Mahler et al., 2001).  
Instruction for using the Airflow Perturbation Device. Use of the APD was 
described in the following steps: 1) seating the participant, 2) placing the disposable 
nose clip to prevent transnasal breathing, 3) placing the mouthpiece securely in the 




elbows on the table to stabilize the upper torso, 5) gently but firmly holding the 
cheeks so that air does not pocket in the buccal spaces, and 6) breathing naturally 
through the mouthpiece until the end of each breathing trial. Before collecting data, 
the investigator described these procedures to the participant, and placed a picture 
illustrating an athlete correctly using the APD on the table in full view as a reminder.  
The athlete was told that she would be performing three 1-minute trials with the APD 
before exercise and then three 1-minute trials immediately after exercise. The time 
interval between the end of one trial and the start of the next was approximately 5 
seconds. Each athlete practiced putting the mouthpiece in her mouth in order to 
ensure correct placement and lip seal which was confirmed by the investigator. 
Instruction for using the treadmill. The athlete was shown the emergency 
stop feature of the treadmill. She was told that either she or the investigator would 
stop the treadmill upon her request or the investigator’s observations. After the 
treadmill stopped, she would be assisted as needed to sit in the chair that was 
positioned within two feet of the treadmill to begin the APD trials. She was given the 
option to stretch prior to exercise or to walk on the treadmill prior to beginning the 
challenge in order to acclimate to the motion.  
Instruction for the exercise challenge and safety monitoring. Information 
about the exercise challenge format and conditions that would result in discontinuing 
the exercise challenge was provided and explained to the participants. The exercise 
challenge followed a progressive incremental protocol (Fletcher et al., 2001; Paridon 
et al., 2006)  whereby the speed and incline of the treadmill were gradually and 




(2 minutes of easy jogging at 4 miles/hour, with a 0% incline in the first minute and a 
1% incline in the second minute). This was followed by a continuous exercise phase 
with either a 0.5 or 1.0 mph increase every 2 minutes and 1% increase in incline at 
alternate 2 minute increments so that a change in either speed or incline was 
occurring each minute with the exception of the ninth and eleventh minutes of 
exercise. The ending speed and incline of the exercise challenge is 7.0 mph and 4%. 
(Appendix C illustrates the exercise challenge.) The duration of the exercise 
challenge did not exceed 12 minutes, a ceiling used by the American Heart 
Association for Pediatric Exercise Challenges (Fletcher et al., 2001; Paridon et al., 
2006). The exercise challenge was discontinued prior to 12 minutes if the athlete’s 
heart rate exceeded the pre-determined maximum rate, if the participant reached a 
subjective symptom rating of 8 on the 10-point modified Borg Dyspnea Scale; or if 
the participant requested discontinuation of the exercise challenge. Upon cessation of 
exercise, the duration of exercise to the nearest second was recorded for later 
analysis.  
Data Analysis 
Control athletes. To address test-retest reliability for the control group, 
intraclass correlation coefficient (ICC) analysis determined the strength of the 
relationship between dependent variables (DVs). The ICC is superior to Pearson 
product moment correlation analysis because it takes into account the correlation in 
individual data pairs along with the correlation between groups of related data 
(Yaffee, 1998). Thus, it describes the strength and agreement of the relationship 




1, 2, and 3) rather than individual paired data. For Question 1, pertaining to test-retest 
reliability of APD-determined measures of Rr during RTB, DVs were Ri, Re, Rr, 
Ri/Re. For Question 2 pertaining to test-retest reliability of APD-determined measures 
of Rr during PEB, DVs were Ri, Re, Rr, Ri/Re, as well as change from rest to exercise 
for Ri, Re, Rr and Ri/Re.  Independent variables were session (3) and trial (3) for each 
of two conditions (RTB and PEB). The same DVs were tested for group effects with 
repeated-measures multivariate analysis of variance (RM-MANOVA), with trial (3), 
session (3), and condition (2) as within-subject variables.  
Athletes with PVFM. To address test-retest reliability for the experimental 
group, intraclass correlation coefficient (ICC) analysis determined the strength of the 
relationship between DVs.  For Question 3, pertaining to test-retest reliability of 
APD-determined measures of Rr during RTB, DVs were Ri, Re, Rr, Ri/Re.  The same 
DVs were tested for group effects with repeated-measures multivariate analysis of 
variance (RM-MANOVA), with trial (3) as the within-subject variable. All statistical 
analyses were performed using SPSS version 18 (IBM Corporation, Armonk, NY).  
Results 
Athletes without PVFM 
Resting tidal breathing. Descriptive statistics for RTB for three sessions and 
three APD trials per session are provided for the control participants in Table 4 for 
DVs Ri, Re, Rr, and Ri/Re. Results for the ICC analyses for RTB for all three trials 
during three sessions are presented in Table 5 for the same DVs. Strong reliability 
(ICC > .95) was demonstrated for all four DVs–Ri, Re, Rr, and Ri/Re. The RM-




(Mahalanobis distances maximum value of 12.78 did not exceed the critical value of 
18.47 for four dependent variables), and linearity. There were no statistically 
significant differences for trial, Wilks’ Lambda = .505, F(7, 5) = .700, p = .678, or for 
session, Wilks’ Lambda = .285, F(7, 5) = 1.793, p = .269.  From the results of ICC 
analysis and RM-MANOVA, test-retest reliability was ascertained between trials and 
sessions for each of the four dependent variables for the control group of athletes 
without PVFM during RTB. Results for the RM-MANOVA for control athletes for 
all conditions (RTB, PEB, and change from RTB to PEB) are reported in Table 6. 
Table 4 
Descriptive Statistics for Resting Tidal Breathing (RTB) for Sessions (3) and Trials 
(3) for Athletes Without PVFM. 
 
 First Trial Second Trial Third Trial 
Variables     M (SD) M (SD) M (SD) 
RTB Session 1    
Ri (cmH2O/L/s) 3.87 (0.56) 3.89 (0.63) 3.96 (0.60) 
Re (cmH2O/L/s) 4.41 (1.14) 4.38 (1.21) 4.39 (1.06) 
Rr (cmH2O/L/s) 4.14 (0.81) 4.13 (0.88) 4.17 (0.78) 
Ri/Re   .904 (.142) .918 (.15) .927 (0.16) 
 
RTB Session 2 
   
Ri (cmH2O/L/s) 3.74 (0.50) 3.74 (0.54) 3.72 (0.59) 
Re (cmH2O/L/s) 4.17 (1.05) 4.05 (1.08) 4.05 (0.93) 
Rr (cmH2O/L/s) 3.95 (0.74) 3.89 (0.77) 3.88 (0.72) 







Intraclass Correlation Coefficients for Athletes Without PVFM across all Trials (3) in 







95% CI p 
     Ri .952 [.896, .984] <.001*** 
     Re .968 [.933, .989] <.001*** 
     Rr .962 [.919, .987] <.001*** 
     Ri/Re .966 [.927, .988] <.001*** 
a
Two-way random effects model with absolute agreement definition 








 First Trial Second Trial Third Trial 
Variables     M (SD) M (SD) M (SD) 
 
RTB Session 3 
   
Ri (cmH2O/L/s)  3.62 (0.48) 3.54 (0.47) 3.46 (0.56) 
Re (cmH2O/L/s) 4.07 (0.77) 4.01 (0.65) 3.96 (0.61) 
Rr (cmH2O/L/s)  3.85 (0.60) 3.78 (0.50) 3.71 (0.54) 





RM-MANOVA Results for Athletes Without PVFM for Resting Tidal Breathing (RTB), 
Post-Exercise Breathing (PEB), and Change(∆) from RTB to PEB using Wilks’ 
Lambda statistic.  
Factor Condition df F η p 
Trial RTB 7, 5 0.70 .495  .678 
 PEB 6, 6 15.37 .939 .002** 
 ∆ RTB to PEB 8, 4 42.63 .988 .001** 
Session RTB 7, 5 1.79 .715   .269 
 PEB 6, 6 2.09 .676 .196 
 ∆ RTB to PEB 8, 4 1.10 .687 .498 
Trial*Session RTB 16, 126 1.02 .089 .438 
 PEB 12, 111 0.54 .049 .883 
 ∆ RTB to PEB 4, 44 0.47 .044 .955 
*p < .05.  **p < .01.   
 
Post-Exercise Breathing. Descriptive statistics for PEB for three sessions of 
three breathing trials per session for the control participants are provided in Table 7 
for DVs Ri, Re, R, and Ri/Re. The results of the ICC analysis during PEB for same 
breathing trial cross-session are presented in Table 8.  Ri, Re, and Rr demonstrated 
strong test-retest reliability (ICC > .88). ICC results varied across the three trials for 
Ri/Re. There is a strong relationship (ICC = .893) for Ri/Re in the first trial across 
sessions, whereas correlations were weaker (ICC= .762 and .576 respectively) in the 
second and third trials. A two-way RM-MANOVA for PEB was conducted to 
compare the results for the four DVs of Ri, Re, Rr, and Ri/Re for the same trial across 




6) = 2.087, p = .196). The main effect for trial was significant (as expected) according 
to the multivariate model (Wilks’ Lambda = .061, F(6, 6) = 15.371, p = .002) because 
exercise impacts APD measures across trials within the same session. There was no 
interaction effect between trial and session (Wilks’ Lambda = .861, F(12, 111) = 
.542, p = .883). 
Table 7 
Descriptive Statistics for Post-Exercise Breathing (PEB) for Sessions (3) and Trials 




   First Trial Second Trial Third Trial 
Variables     M (SD) M (SD) M (SD) 
 
PEB Session 1 
   
Ri (cmH2O/L/s) 3.70 (0.52) 3.45 (0.35) 3.44 (0.40) 
Re (cmH2O/L/s) 3.35 (0.37) 3.44 (0.47) 3.55 (0.62) 
Rr (cmH2O/L/s) 3.53 (0.37) 3.44 (0.38) 3.50 (0.48) 
Ri/Re   1.11 (0.16) 1.01 (0.10) 0.98 (0.11) 
PEB Session 2    
Ri (cmH2O/L/s) 3.75 (0.52) 3.45 (0.60) 3.55 (0.58) 
Re (cmH2O/L/s) 3.47 (0.48) 3.52 (0.61) 3.58 (0.69) 
Rr (cmH2O/L/s) 3.61 (0.42) 3.48 (0.58) 3.57 (0.61) 
Ri/Re  1.09 (0.17) .983 (0.10) 1.00 (0.01) 
 
PEB Session 3 
   
Ri (cmH2O/L/s) 3.70 (0.70) 3.51 (0.77) 3.48 (0.69) 
Re (cmH2O/L/s) 3.37(0.43) 3.40 (0.57) 3.45 (0.58) 
Rr (cmH2O/L/s) 3.54 (0.46) 3.45 (0.65) 3.47 (0.60) 





Cross-Session Intraclass Correlation Coefficients for Athletes Without PVFM for 3 





 95% CI p 
Ri     
Trial 1 .903 [0.740, 0.970] <.001*** 
Trial 2 .886 [0.695, 0.964] <.001*** 
Trial 3 .885 [0.696, 0.964] <.001*** 
Re    
Trial 1 .927 [0.811, 0.977] <.001*** 
Trial 2 .948 [0.867, 0.984] <.001*** 
Trial 3 .940 [0.843, 0.981] <.001*** 
Rr 
Trial 1 
.926 [0.808, 0.977] <.001*** 
Trial 2 .931 [0.816, 0.978] <.001*** 
      Trial 3 .940 [0.844, 0.981] <.001*** 
Ri/Re    
Trial 1 .893 [0.714, 0.967] <.001*** 
Trial 2 .762 [0.389, 0.925]  .002** 
Trial 3 .576 [0.159, 0.869] 
 
              .048* 
a
Two-way random effects model with absolute agreement definition 
* p < .05. **p < .01. ***p < .001. 
 
Change in Rr from RTB to PEB. The variables measuring change from rest 
to exercise in percent for Ri, Re, R, and Ri/Re were analyzed for test-retest reliability 
and statistical significance using ICC and RM-MANOVA. Descriptive statistics for 
the control group are presented in Table 9. The ICC analysis results are presented in 




and R during RTB and PEB. The correlation is very weak for ∆Ri, especially trials 2 
and 3, with the confidence interval covering a wide range. Similarly, the second and 
third trials for ∆R reveal weak correlations. A two-way RM-MANOVA was 
conducted to analyze the results for change from RTB to PEB for the four DVs (Ri, 
Re, R, and Ri/Re) for the same trial across sessions. There was no statistically 
significant effect for session, Wilks’ Lambda = .313, F (8, 4) = 1.097, p = .687.  
There was statistical significance for trial, Wilks’ Lambda = .012, F (8, 4) = 42.628, p 
= .001. There was no interaction effect between trial and session, Wilks’ Lambda = 

























 First Trial Second Trial Third Trial 
Variables     M (SD) M (SD) M (SD) 
Post-exercise Change Session 1    
∆Ri  -4.10% (13.26) -10.75%  (9.10) -11.22%  (6.42) 
∆Re  -20.24% (17.93) -19.15% (13.93) -16.73% (14.49) 
∆Rr  -13.01% (13.65) -15.53% (10.31) -14.37% (11.07) 
∆Ri/Re   24.54% (25.36)  12.71%  (17.37)  8.62%  (14.19) 
 
Post-exercise Change Session 2 
   
∆Ri   0.81%  (9.72) -7.91% (7.27) -5.00%  (7.57) 
∆Re  -13.20% (15.41) -12.33% (11.24) -11.23% (10.85) 
∆Rr  -6.45% (10.50)     -10.48%  (7.38) -8.46%  (7.45) 
∆Ri/Re   18.98% (25.84)   6.57% (15.53)    8.35% (13.86) 
Post-exercise Change 
Session 3 
   
∆Ri    4.60% (13.23)  -1.19% (14.83)  -1.87% (12.21) 
∆Re  -14.69% (13.31) -15.06%  (8.65) -13.65%  (9.65) 
∆Rr  -5.95%  (9.50)  -8.90%  (8.89)  -8.38%  (8.71) 






Cross-Session Intraclass Correlation Coefficient Analysis for Post-Exercise Changes 






95% CI p 
 ∆Ri    
Trial 1  .350 [-0.583, 0.789] .176 
Trial 2 -.139 [-1.533, 0.613] .586 
Trial 3 -.037 [-1.172, 0.635] .509 
∆Re    
Trial 1  .839 [0.589, 0.949]    < .001*** 
Trial 2  .697 [0.242, 0.903]     .006** 
Trial 3  .691 [0.206, 0.903]     .009** 
∆Rr    
Trial 1  .659 [0.162, 0.890]     .010** 
Trial 2 -.094 [-1.636, 0.643] .548 
Trial 3 .442 [-0.339, 0.818] .102 
 ∆Ri/Re    
Trial 1 .861 [0.638, 0.956]    <.001*** 
Trial 2 .790 [0.468, 0.933]    <.001*** 
Trial 3 .696 [0.219, 0.904]    .008** 
a
Two-way random effects model with absolute agreement definition 
* p < .05. **p < .01. ***p <.001. 
Athletes with PVFM 
Resting Tidal Breathing. The same statistical tests that were used for the 
control group were also conducted for the variables in the experimental group which 
was assessed for three trials of RTB during only one session. Table 11 shows 
descriptive statistics and Table 12 shows the results of the ICC analysis for four DVs 




were observed for all variables (ICC ≥ .968 for Ri, Re, and Rr; and ICC =.788 for 
Ri/Re). The lower ICC for Ri/Re is attributed to Ri and Re varying in different 
directions despite their overall consistency.  A one-way RM-MANOVA was 
conducted for breathing trial and the dependent variables Ri, Re, Rr, and Ri/Re; it 
failed to demonstrate significant differences (Wilks’ Lambda = .520, F(6, 6) = .925, p 
= .537).  
Table 11 
Descriptive Statistics for Resting Tidal Breathing (RTB) in Athletes with PVFM for 3 
Consecutive Trials.  
 
Table 12 
Cross-Trial Intraclass Correlation Coefficients for Athletes with PVFM during 
Resting Tidal Breathing (RTB). 







95% CI p 
    
     Ri .968 [0.916, 0.990] <.001*** 
     Re .974 [0.929, 0.992] <.001*** 
     Rr .976 [0.936, 0.993] <.001*** 
     Ri/Re .790 [0.457, 0.934]   .001** 
a
One-way random effects model with absolute agreement definition 
* p < .05. **p < .01. ***p < .001. 
 
 First Trial Second Trial Third Trial 
Variables     M (SD) Mean (SD) Mean (SD) 
 RTB    
Ri (cmH2O/L/s) 3.03  (.66) 2.88  (.67) 2.90  (.61) 
Re (cmH2O/L/s)            3.23  (.80) 3.13  (.80) 3.04  (.73) 
Rr (cmH2O/L/s) 3.13  (.72) 3.01  (.70) 2.97  (.65) 





Results of this study show that Ri, Re, Rr, and Ri/Re measures obtained with 
the APD during RTB have strong test-retest reliability. For the control athletes, this 
was demonstrated across three consecutive trials within the same session, and across 
three separate sessions during RTB using ICC and RM-MANOVA analyses. For the 
athletes with PVFM, the same measures also demonstrated strong test-retest 
reliability across 3 trials within one session during RTB.   
Immediately following exercise, these measures remained highly reliable in 
the trials of the same order across three sessions, suggesting that the respiratory 
system responds to exercise in a consistent manner in athletically trained young 
females who do not have asthma or PVFM. Although measures of post-exercise 
change were strongly correlated across sessions for ΔRe and ΔRi/Re, this was not 
observed for ΔRi and ΔRr (the latter influenced by the former).  
Using both ICC and RM-MANOVA was important to investigate relatedness 
and potential differences in the data and revealed several important implications. 
(1) The results provided by both analyses confirmed the consistency of Rr measures 
obtained with the APD during very different conditions – breathing during rest and 
breathing immediately following exercise. Significant changes in respiratory 
resistance may indicate varying respiratory physiology.  (2)  Based upon the strong 
test-retest reliability for Ri and Re during RTB for both athlete groups, their means 
across three trials within one session are accurate representations of baseline 
conditions. Post hoc analyses for statistically significant findings from the RM-




within and between-group differences.  (3) Because the respiratory system changes 
differently in inspiratory and expiratory phases when there is a PVFM episode, using 
both Ri and Re rather than their mean (Rr) will provide information more specific to 
PVFM and more likely will reveal changes in respiratory resistances that otherwise 
can be masked by averaging Ri and Re into Rr. Eliminating the dependent variable Rr 
(mean of Ri and Re) from further analyses in Study 3 as explained in (1), will also 
reduce the number of DVs, thus strengthening future analyses. (4) Contrary to 
expectation, ΔRi and ΔRr were not reliable. ΔRe and ΔRi/Re, although statistically 
reliable, showed weaker ICCs compared to Ri, Re, R, and Ri/Re. These percent change 
variables, therefore, were not included in the subsequent study.  
Caveats 
The study hypotheses were supported, although the present study had several 
limitations.  Cross-session reliability would have been assessed in athletes with 
PVFM during RTB and PEB if they had participated in at least two baseline sessions 
prior to receiving therapy. The decision not to do this was made purposefully, as 
previously explained in the Methods Section. Many athletes return to LCC after the 
initial diagnostic/treatment session for additional therapy sessions, that allows re-
assessment of Rr during RTB. However, it is unknown whether the previous 
intervention provided by the SLP might have changed Rr baselines. This study was 
designed to exclude any potential influence of previous treatment; therefore, no 
athlete who had been treated previously was enrolled into this study.  
The second limitation involved scheduling sessions for the athletes in the 




regularly scheduled time interval as was initially designed (i.e., once per week for 
three consecutive weeks). Although the statistical mode was 7 days between sessions, 
two challenge sessions were conducted on the same day at minimally one hour 
intervals for four athletes, and almost one year elapsed between one athlete’s second 
and third sessions. Interestingly, all four athletes who participated in two sessions 
during the same day completed the full 12 minutes of exercise for both exercise 
challenges suggesting that two sessions within the same day did not negatively 
influence exercise duration. Overall, their busy schedules, the commute to the clinic, 
and for some, their hesitancy to return after the first session, interfered with regular 
attendance. Despite these factors, test-retest reliability remained strong.  
Conclusions 
The results from the previous study (Study 1) demonstrated that changes in 
glottal area measured from a two-dimensional aerial view of the larynx correlated 
well with changes in Rr as measured by the APD. The results from the present study 
(Study 2) confirm strong test-retest reliability of Rr measured by the APD during 
RTB in healthy control athletes and athletes with PVFM. The same strong reliability 
is also observed across sessions during PEB in control participants. The subsequent 
study will examine the effect of exercise on Ri and Re within and between athlete 






Chapter 4: Study 3 Effect of Exercise on Athletes  
With and Without PVFM 
Aerobic exercise requires changes in the respiratory, circulatory, and 
metabolic systems, to meet the increased demand of oxygen and carbon dioxide 
exchange. The goal of the respiratory system during exercise is to maintain high 
airflow with low respiratory resistance (Rr) and with a minimum amount of energy 
expenditure (England & Bartlett, 1982). This is accomplished, in part, through 
increased respiratory rate and greater air volume exchange. The mathematic product 
of tidal volume during inspiration and expiration and respiratory rate during one 
minute of breathing is called minute ventilation (Rundell & Slee, 2008). It varies 
greatly when transitioning from resting tidal breathing (RTB) to exercise breathing 
(EB). For example, respiratory rate during RTB is approximately 15 breaths per 
minute, as contrasted with peak exercise where respiratory rate can increase to 40 
breaths per minute (Jones, 1984; Templer, VonDoersten, Quigley, Scott, & Davis, 
1991). Minute ventilation during RTB averages 5-10 L/min, whereas during EB it 
may increase to 40-60 L/min coinciding with a higher velocity of airflow. 
Airflow within the airways can be either laminar or turbulent. Laminar flow is 
found in the lower, smaller airways, and turbulent flow results from the mixing of 
gases in the larger airways of the trachea, larynx, and oral and nasal cavities (Dekker, 
1961; Ferris, 1963, Templer et al., 1991). When airflow velocity increases (e.g., 




increasingly more turbulent (Dekker, 1961). This causes increased Rr (Templer et al., 
1991; Titze, 1994), such that during exercise the upper airway has a disproportionate 
increase in resistance compared to the lower airways (Hurbis & Schild, 1991).  
During RTB, Ferris et al. (1963) observed that when breathing through the 
mouth, the upper airway contributed 28% to total respiratory resistance and that the 
larynx alone contributed 16%. The remaining resistance derives from the lower 
airways, lungs, and chest wall. During RTB, the vocal folds abduct for inspiration and 
adduct slightly for expiration (Balkissoon, Beaty, et al., 1999; England & Bartlett, 
1982; Templer et al., 1991).  Re during RTB was reported to be greater than Ri in 
adult and pediatric participants (Dekker, 1961, Ferris et al., 1963; Johnson et al., 
2007; Silverman et al., 2005), suggesting the inverse relationship of GA and Rr 
(England & Bartlett, 1982). The glottal narrowing that occurs during expiration 
functions as a braking mechanism to control the rate of airflow as the lungs return to 
resting volume (Balkissoon, 2007; Collett, Brancatisano & Engel, 1983; England & 
Bartlett; Templer et al., 1982).   
Increases in airflow velocity are accompanied by increases in the laryngeal 
contribution to respiratory resistance (Ferris et al., 1963). The larynx, considered to 
be the lower boundary of the upper airway, accommodates higher airflow levels 
primarily through widening of the glottis. Beaty et al. (1999) observed that at higher 
airflow levels associated with exercise, the vocal folds maintained a relatively fixed 
abducted posture during both inspiration and expiration in healthy athletes.  In other 
words, the normal braking mechanism provided by the vocal folds during expiration 




supraglottic larynx dilates and rotates anteriorly, and the epiglottis flattens (Beaty et 
al., 1999; Hurbis & Schild, 1991). By doing so, glottal area increases, thereby 
reducing turbulence and resistance in the upper airway. If, however, GA does not 
change proportionately with increased airflow, then Rr will increase during 
inspiration and/or expiration, making it difficult to breathe (Beaty et al., 1999; 
England & Bartlett, 1982; Hurbis & Schild, 1991). This can result in the sensation of 
dyspnea, defined as “consciousness of the necessity for increased respiratory effort" 
(Jones, 1984, p.14).   
Several studies have investigated changes in GA with continuous laryngeal 
imaging before and during exercise among healthy athletes, athletes with exercise-
induced asthma (EIA), and athletes with paradoxical vocal fold motion (PVFM). 
Because athletes with PVFM are commonly misdiagnosed as having asthma, it is 
important to understand differences in glottal area during inspiration and expiration 
observed during laryngoscopy for all three groups. When transitioning from RTB to 
EB and continuing throughout EB, inspiratory GA (GAi) tends to increase or remain 
unchanged for healthy athletes and those with EIA (Beaty et al., 1999; Hubris & 
Schild, 1991). Athletes with PVFM respond very differently. Two athletes with 
PVFM in the study by Beaty et al. (1999) demonstrated a decrease in GAi that 
corresponded with their complaints of dyspnea.  Similarly, Heinle et al. (2003) 
performed laryngoscopy during bicycle ergometry on 15 adolescents suspected of 
having PVFM. They observed vocal fold adduction and/or exercise-induced 




Vocal fold movement during expiration when transitioning from RTB to EB 
differs from that during inspiration. For healthy athletes, glottal area during expiration 
(GAe) is consistently reported to be greater during EB than during RTB, although it is 
still relatively smaller during expiration than inspiration during EB (England & 
Barlett, 1982; Hurbis & Schild, 1991). This difference between RTB and EB in the 
relative GA during inspiration and expiration has been demonstrated in healthy 
athletes (Beaty et al., 1999; Hurbis & Schild, 1991; Tervonen et al., 2009). Whereas 
PVFM negatively impacts GAi, asthma affects GAe.  Athletes with moderate asthma 
did not demonstrate an increase in GAe during EB; rather GAe remained consistent 
with that of RTB.  Athletes with severe asthma experienced a decrease in GAe during 
and following exercise compared with that during RTB, despite high airflow rates 
(Hurbis & Schild, 1991). For people with asthma, laryngeal airway constriction 
during expiration may offer continuous positive airway pressure that is needed to 
maintain lower airway patency and reduce asthma severity (Collett et al., 1983; 
England & Bartlett, 1982; Hurbis & Schild, 1991). The findings for healthy athletes 
suggest that the larynx normally offers less resistance to airflow during exercise than 
at rest, most likely associated with increased minute ventilation and in response to 
increased airflow turbulence (England & Barlett, 1982; Hurbis & Schild, 1991), 
whereas the larynx continues to provide a braking action during expiration in athletes 
with asthma. 
The aforementioned research investigated changes in GA prior to and during 
exercise through continuous laryngoscopy. Often pulmonary function flow-volume 




lower versus upper airway obstruction (the former is characteristic of asthma, the 
latter of PVFM). Respiratory resistance was not assessed during exercise, most likely 
because of the difficulty of simultaneously viewing the larynx and assessing 
pulmonary function during exercise. There has been only one published study where 
Rr was measured using the Airflow Perturbation Device (APD) in athletes (Silverman 
et al., 2005). Twelve non-asthmatic adult volunteers exercised on a treadmill 
achieving 85% of HRmax. Rr was measured prior to exercise, after a brief warm-up 
exercise period, and then immediately and continuously for 6 minutes after exercise 
ceased.  Their results indicated an “exercise effect” such that a statistically significant 
decrease of Rr after exercise was detected for 55 seconds during inspiration and 35 
seconds during expiration.  
To date, there are no known studies that have investigated changes in Rr in 
athletes diagnosed with PVFM. Information of how Ri and Re change during exercise 
in athletes with PVFM and how resistance differs between athletes with PVFM and a 
control group of athletes without PVFM, can elucidate potential abnormalities in 
respiratory function that occur with exercise-induced PVFM. Depending upon the 
findings for the two athlete groups, measures of Ri and Re can potentially provide 
quantitative data to screen athletes with complaints suggestive of PVFM as well as to 
provide treatment outcome measures for athletes diagnosed with PVFM. 
This study builds upon the two previous ones in this dissertation that 
addressed the validity and reliability of Rr measured by the APD developed by 
Lausted and Johnson (1999). The first study assessed the relationship between Rr and 




correlated and well timed with changes in Rr. The second study suggested strong test-
retest reliability of Rr during RTB in both athlete groups and during PEB in control 
athletes.  Measures with weak reliability (∆Ri, ∆Rr) were not selected for this study 
because differences revealed by these variables might not indicate an actual change in 
the respiratory system. Although ∆Re and ∆Ri/Re had strong reliability, they too were 
eliminated from further analyses since ∆Ri and ∆R were eliminated. Further, although 
strong test-retest reliability was demonstrated in Study 2 for the dependent variable Rr 
(the mean of Ri and Re), it was eliminated from the present study because it failed to 
demonstrate the discrepancy between Ri and Re that is characteristic of PVFM. 
The purpose of this study was to investigate changes in respiratory resistance, 
exercise duration, and dyspnea ratings following exercise in female teenage athletes 
with PVFM (experimental group) and  athletes without PVFM (control group). The 
present study adopted the dependent variables with strong reliability (Ri, Re, Ri/Re) 
and aimed to answer the following within-group research questions: 1) To what 
extent do APD-determined measures of Rr change from RTB to PEB in athletes 
without PVFM and athletes with PVFM?  2) To what extent do measures of Rr 
change over a 2-minute post-exercise period in athletes without PVFM and athletes 
with PVFM?  It also aimed to answer the following between-group research 
questions: 1) Do APD-determined measures of Rr for RTB and PEB differ between 
athletes with and without PVFM?  2) Do athletes without PVFM outperform athletes 
with PVFM in terms of running duration as measured during the exercise challenge 
test? 3) Do severity ratings of dyspnea reported at the end of an exercise challenge 




Based on previous literature and clinical experience, the following hypotheses 
are offered. For athletes without PVFM, who have no known respiratory or laryngeal 
problems, 1) Ri will decrease during PEB as compared with RTB; 2) Re will decrease 
during PEB as compared with RTB; and 3) Ri and Re will decrease the most during 
the first minute after exercise with the subsequent trial showing a progressive 
recovery toward Ri and Re during RTB. For athletes with PVFM, characterized by 
dyspnea and laryngeal constriction during an exercise-induced episode, 1) Ri during 
PEB will be greater than that during RTB; 2) Re may increase after exercise, but to a 
lesser extent than Ri; and 3) the most substantial change in Ri and Re will occur 
during the first minute after exercise (PEB1); thereafter, Ri and Re will demonstrate a 
progressive return toward baseline levels.  
For the between-group comparison, the two groups are expected to have 
comparable Ri and Re during RTB. This hypothesis is based on the common 
observation that PVFM is asymptomatic during RTB, and because both groups are 
comparable in gender, age, size, and exercise conditioning. Following exercise, 
athletes with PVFM are expected to have greater Ri values and possibly greater Re 
values compared to athletes without PVFM because of reduced GA. It is also 
anticipated that athletes with PVFM will exercise for shorter durations and have 
higher dyspnea ratings than athletes without PVFM. 
Method 
Participants 
The same experimental and control participants described in Study 2 





The equipment, facility, personnel, participant selection and consent, and 
experimental procedures for the present study are the same as those described in 
Study 2. Although athletes without PVFM participated in three separate sessions 
performing three RTB and three PEB trials per session, data from only the first 
session are used in this study so that the novelty of the exercise challenge is matched 
for both groups. The athletes with PVFM participated in only one session when they 
performed three trials of RTB and either two or three trials of PEB. Seven of the 
twelve athletes with PVFM did not perform the third PEB trial because they were 
visibly distressed by dyspnea while breathing into the APD following exercise for the 
first two trials (PEB1 and PEB2). The investigator reminded them that they could stop 
their participation at any time, and these athletes chose to stop after PEB2.        
Data Analysis  
All analyses were conducted using SPSS version 18 (IBM Corporation, 
Armonk, NY). To address the effects of exercise on Ri and Re, a repeated-measures 
multivariate analysis of variance (RM-MANOVA) was conducted with group (with 
and without PVFM) as the between-subjects factor, and trial (1 and 2) and condition 
(RTB and PEB) as within-subjects factors.  The ratio of Ri to Re was analyzed in a 
separate repeated-measures analysis of variance (RM-ANOVA) using the same 
model. Results for Wilks’ Lambda test are reported. The assumption of sphericity for 
the analyses of variance was met according to Mauchley’s test.  The RM-MANOVA 
revealed dependent main effects and interaction effects that were further tested 




significant dependent variables was accomplished with related samples t tests with 
Bonferroni corrections (with alpha level established by dividing .05 by the number of 
t tests). Significant between-group differences were further investigated through 
univariate ANOVA. 
Differences between groups for exercise duration were investigated using an 
independent samples t test.  Between-group difference in dyspnea ratings from the 
modified Borg Dyspnea Scale (Borg, 1998) was investigated using the Mann-
Whitney U test because this scale produces ordinal data. The α level for significance 
was determined a priori to be .05 for each analysis. 
Results 
Changes in Rr from RTB to PEB – Overview for both Athlete Groups  
The results for athletes with PVFM and the control participants are described 
separately, followed by the results of between-group comparisons. Descriptive 
statistics for Ri, Re, and Ri/Re in both groups during two pre- and two post-exercise 
trials are presented in Table 13. The results of the RM-MANOVA for respiratory 
resistance during the two separate phases of breathing (Ri and Re) are listed in Table 
14, and univariate RM-ANOVAs for Ri, Re, and the derived variable Ri/Re are listed 









Descriptive Statistics for Respiratory Resistance for Two1-Minute Breathing Trials 
during Resting Tidal Breathing (RTB) and Post-Exercise Breathing (PEB) in 12 
Athletes without PVFM (Control) and 12 Athletes with PVFM. 
Group          Control              PVFM 
Trial 1 2 1 2 
     M (SD) M (SD)     M (SD) M (SD) 
RTB 
    
   Ri (cmH2O/L/s) 3.87 (0.56) 3.89 (0.63) 3.03 (0.66) 2.88 (0.67) 
   Re (cmH2O/L/s) 4.41 (1.1) 4.38 (1.2) 3.23 (0.80) 3.13 (0.80) 
   Ri/Re   0.904 (0.14) 0.917 (0.15) 0.949 (0.08) 0.927 (0.09) 
PEB     
   Ri (cmH2O/L/s) 3.70 (0.52) 3.45 (0.35) 4.36 (0.72) 3.59 (0.51) 
   Re (cmH2O/L/s) 3.35 (0.37) 3.44 (0.47) 3.61 (0.68) 3.45 (0.41) 
   Ri/Re  1.11 (0.16) 1.01 (0.10) 1.21 (0.15) 1.04 (0.12) 
 
When Ri and Re were collapsed in the RM-MANOVA, main effects for 
breathing condition and trial number were statistically significant, as were the 
interactions of condition by group, trial by group, and condition by trial. The group 
main effect and the 3-way interaction did not meet statistical significance. When 
analyzed separately, the main effects of condition and trial were statistically 
significant for Ri, but neither differed significantly for Re. The main effect of group 
did not meet criterion for statistical significance for Ri or Re, but the interaction of 




group and condition by trial also met statistical significance for Ri (only). The 3-way 
interaction of condition, trial, and group was not significant for either Ri or Re.  
Table 14 
 Results from RM-MANOVA for Inspiratory Resistance (Ri) and Expiratory 
Resistance (Re) for Two Groups of Athletes (With and Without PVFM) for Resting 
and Exercise Breathing (Condition) across Two Trials. 
Variable df F ή p power 
Group 2, 21  2.15 .170   .141  .391 
Condition 2, 21 21.37 .671 <.001   *** 1.000 
Trial  2, 21 28.20 .729 <.001   *** 1.000 
Condition*Group 2, 21 28.95 .734 <.001   *** 1.000 
Trial*Group 2, 21  8.55 .449    .002   **  .940 
Condition*Trial 2, 21 14.55 .581 <.001   ***  .996 
Condition 
*Trial*Group  
2, 21  1.45  .121    .257  .275 












Table 15  
Results from Univariate RM-ANOVAs for Inspiratory Resistance (Ri) and Expiratory 
Resistance (Re) and Inspiratory-to-Expiratory Resistance Ratio (Ri/Re) for Athletes 
without PVFM and Athletes with PVFM. 
Wilks’ Lambda 
df F ή p power 
Group      
     Ri 1, 22  1.44 .062  .242   .210 
     Re 1, 22  3.89 .151  .061   .471 
     Ri/Re 1, 22  1.80 .076  .193   .250 
Condition 
     
     Ri 1, 22 17.91 .449 <.001   ***   .981 
     Re 1, 22  4.24 .162   .051   .504 
     Ri/Re 1, 22 30.32 .580 <.001   *** 1.000 
Trial  
     
     Ri 1, 22 50.92 .698 <.001   *** 1.000 
     Re 1, 22  1.16 .050   .292   .178 
     Ri/Re 1, 22 25.76 .539 <.001   ***   .998 
Condition*Group      
     Ri 1, 22 60.65 .734 <.001   *** 1.000 
     Re 1, 22 18.42 .456 <.001   ***  .984 
     Ri/Re 1, 22   0.39 .018    .536  .092 
Trial*Group      
     Ri 1, 22 17.63 .445 <.001   ***  .980 
     Re 1, 22  2.63 .107   .199  .342 
 Ri/Re 1, 22   3.57 .140   .072  .439 





df F ή p power 
Condition*Trial      
     Ri 1, 22 20.43 .482 <.001   ***  .991 
     Re 1, 22  0.065 .003   .801  .057 
     Ri/Re 1, 22 17.75 .447 <.001   ***  .980 
Condition 
*Trial*Group  
     
     Ri 1, 22  3.03 .121  .096  .384 
     Re 1, 22  0.740 .033  .399  .131 
     Ri/Re 1, 22   0.29 .013  .594  .081 
*p < .05.  **p < .01. ***p< .001.   
Inspiratory-to-expiratory resistance ratio (Ri/Re), when analyzed in a separate 
RM-ANOVA, differed significantly across condition and trial. A significant 
interaction between condition and trial revealed that Ri/Re increased from RTB to 
PEB, and decreased from Trial 1 to Trial 2 when collapsed across groups. Post-hoc 
analysis (Table 16) revealed that when the two trials of Ri/Re during RTB were 
averaged, the mean of Ri/Re during RTB significantly differed from PEB1and PEB2. 
Likewise, there was a statistically significant difference between PEB1 and PEB2. No 









Table 16.  
 Post-hoc Analyses for Statistically Significant Findings from Omnibus Univariate 
test for Inspiratory-to-expiratory ratio (Ri/Re) during Resting Tidal Breathing (RTB) 
and Post-Exercise Breathing (PEB) 
Variable Ri/Re df t p 
Contrasts    
     Average of  RTB1-2 and PEB1 23  -6.11 <.001** 
     Average of  RTB1-2 and PEB2 23  -3.86   .001** 
     PEB1 and PEB2 23   4.98 <.001** 
*p < .017.  **p < .003. 
Within-Group Results: Athletes without PVFM (Control Group) 
 Inspiratory resistance. The descriptive statistics for the athletes without 
PVFM revealed that Ri was less than Re for both trials of RTB (Table 13). During 
both trials of PEB, Ri was lower than it was during RTB, although Ri for PEB1 
decreased less than for PEB2 (Figure 8).  The change from RTB to PEB2 was 
statistically significant, as was the decrease of Ri from PEB1 to PEB2. Post-hoc 
related-samples t-test results for all significant variables from the MANOVA and 
ANOVAs for the control group of athletes without PVFM are reported in Table 17. 
The average of RTB1-2 was used (based upon strong test-retest results from Study 2), 







Table 17.     
Post-hoc Related-Samples t tests for Significant ANOVA Omnibus Results for 
Inspiratory Resistance (Ri), Expiratory Resistance (Re) and Inspiratory-to-Expiratory 
Resistance Ratio (Ri/Re) for Athletes Without PVFM. 
Contrasts  df t p 
Ri    
     Average of RTB1-2 and PEB1 11  1.09 .297 
     Average of RTB1-2 and PEB2 11 3.69 .004* 
     PEB1 and PEB2 11   3.01 .012* 
Re    
     Average of RTB1-2 and PEB1 11  3.29 .007* 
     Average of RTB1-2 and PEB2 11  3.62 .004* 
     PEB1 and PEB2 11 -0.92 .379 
 
Ri/Re 
   
     Average of RTB1-2 and PEB1 11 -3.29 .007* 
     Average of RTB1-2 and PEB2 11 -2.37 .037 
     PEB1 and PEB2 11 3.22 .008* 
*p < .017.  **p < .003. 
Expiratory resistance. Re was considerably lower for both trials of PEB as 
compared to RTB for the control group (Figure 8). The greater change occurred 
during PEB1. By PEB2, the summary statistics suggested a recovery towards its level 




(standard deviation) was observed for Re (as compared with Ri) across both trials of 
RTB (Table 13). Re during PEB1 and PEB2 did not differ significantly. 
    
Figure 8. Mean inspiratory (black) and expiratory (grey) resistances for athletes without 
PVFM for two trials of two breathing conditions (resting-tidal and post-exercise 
breathing). Error bars = +/- 1 SD. 
 Ratio of inspiratory to expiratory resistance. Ri/Re changed from a ratio < 
1.0 during both trials of RTB to a ratio > 1.0 during both trials of PEB, reaching 
statistical significance for PEB1 in the athletes without PVFM. This is related to the 
proportionally greater decrease in Re as compared with Ri during PEB. Ri/Re also 
differed significantly between the two trials of PEB.   
Within-Group Results: Athletes with PVFM (Experimental Group) 
 Inspiratory resistance.  During RTB, Ri was relatively consistent across 
trials for the athletes with PVFM (Table 13). Immediately following exercise, a 
dramatic change was observed whereby Ri was highest for PEB1, which was then 
followed by a partial recovery during PEB2 toward the level of Ri during RTB (Figure 




Ri from RTB to PEB for trial 1 and trial 2, and between trials PEB1 and PEB2. The 
average of RTB1-2 was used to reduce the number of post-hoc paired comparisons for 
athletes with PVFM (based upon strong test-retest results from Study 2).  
Expiratory resistance. The values for Re were greater during both trials of 
PEB as compared with both trials of RTB. Post-hoc related-samples t tests for 
comparing RTB2 to PEB1 and PEB2, were not statistically significant after Bonferroni 
adjustment. The difference between PEB trials was not statistically significant.  
     
Figure 9. Mean inspiratory (black) and expiratory (grey) resistances for athletes with 
PVFM for two trials of two breathing conditions (resting-tidal and post-exercise 
breathing). Error bars = +/- 1 SD. 
Ratio of inspiratory to expiratory resistance for athletes with PVFM. 
Respiratory resistance values during RTB were smaller for Ri than for Re yielding a 
ratio < 1.0. The change from RTB to PEB was statistically significant for PEB1 and 






Table 18.    
Post-hoc Related Samples t tests for Significant ANOVA Omnibus Results for 
Inspiratory Resistance (Ri), Expiratory Resistance (Re) and Inspiratory-to Expiratory-
Resistance Ratio (Ri/Re) for Athletes With PVFM. 
Contrasts df t p 
Ri    
     Average of RTB1-2 and PEB1 11 -11.64 <.001** 
     Average of RTB1-2 and PEB2 11 -4.90 <.001** 
     PEB1 and PEB2 11   5.85 <.001** 
Re    
     Average of RTB1-2 and PEB1 11  -2.70    .021 
     Average of RTB1-2 and PEB2 11  -1.97    .075 
     PEB1 and PEB2 11   1.06    .312 
Ri/Re    
     Average of RTB1-2 and PEB1 11 -5.66 <.001** 
     Average of RTB1-2 and PEB2 11 -3.07 .011* 
     PEB1 and PEB2 11  3.23 .002** 
*p < .017.  **p < .003. 
Between-Group Comparison Results  
 Respiratory resistance during resting tidal breathing.  During both trials of 
RTB, athletes with PVFM had lower Ri values than the athletes without PVFM 
(Table 13) as illustrated in Figure 10. Post-hoc one-way ANOVA results for all 
significant group variables from the R-M ANOVAs for athletes with and without 




PVFM had statistically significant lower Ri values for both trials -- RTB1 and RTB2. 
Likewise, athletes with PVFM had statistically significantly lower Re values than the 
athletes without PVFM for both trials – RTB1 and RTB2. The two groups did not 
differ significantly for Ri/Re during RTB.  
  
 
 Figure 10. Mean inspiratory (top) and expiratory (bottom) resistances for two groups 
of athletes (with PVFM = grey; without PVFM = black) for two trials of two 
breathing conditions (resting-tidal and post-exercise breathing). Error bars = +/- 1 SD. 
Respiratory resistance during post-exercise breathing. During the first trial 
of PEB, athletes with PVFM had substantially higher Ri values than the athletes 




Figure 10. One-way ANOVA post hoc test results (Table 19) revealed statistically 
significant differences for trial 1.  However, by PEB2, the two groups did not differ 
significantly for Ri.  The two groups did not differ significantly for Re for either trial 
of PEB, although athletes with PVFM demonstrated an increase during PEB1 from 
their Re during RTB, and athletes without PVFM demonstrated a decrease in Re. By 
PEB2, both groups had similar values for Re. The groups did not differ significantly 
for Ri/Re for PEB1 or PEB2 (Figure 11). 
 
Figure 11. Mean inspiratory-to-expiratory resistance ratiofor two groups of athletes 
(with PVFM = grey; without PVFM = black) for two trials of two breathing 









Table 19.    .  
Post-hoc Between-Group ANOVA results for Significant Univariate Omnibus Tests 
for Inspiratory Resistance (Ri), Expiratory Resistance (Re) and Inspiratory-to-
Expiratory Resistance Ratio (Ri/Re). 
Condition df F p 
RTB    
     Ri1  1,22 11.11 .003** 
     Ri2    1,22 14.26 .001** 
     Re1 1,22   8.66 .008** 
     Re2 1,22   9.30 .007** 
     Ri/Re1 1,22   0.92 .349 
     Ri/Re2 1,22   0.04 .838 
PEB    
     Ri1  1,22  6.65 .017* 
     Ri2    1,22  0.65 .427 
     Re1 1,22 1.41 .248 
     Re2 1,22 0.00 .948 
     Ri/Re1 1,22 2.67 .116 
     Ri/Re2 1,22 0.51 .482 





Exercise duration and Borg dyspnea ratings.  Descriptive statistics for 
exercise duration and dyspnea ratings from the modified Borg Dyspnea Scale are 
reported in Table 20. For exercise duration, an independent samples t test (one-tailed) 
revealed statistically significant between-group differences, t(22)= 3.502, p=.001. 
Athletes with PVFM discontinued the exercise challenge test sooner than the athletes 
without PVFM (Figure 12).  
Borg dyspnea ratings differed significantly between groups, Mann-Whitney 
U= 5.00, z = -3.93, p <.001. On average, athletes without PVFM rated dyspnea 3.6 
whereas athletes with PVFM rated dyspnea 7.4 (Figure 12).  
Table 20  
Mean (and SD) Exercise Duration and Borg Dyspnea Rating in 12 Athletes without 
PVFM (Control) and 12 Athletes with PVFM  
Group                   Control PVFM  
 Mean (SD) Min-Max Mean (SD) Min-Max 
Exercise Duration 
(min) 
10.91 (1.04) 9.08-12.00 9.04 (1.53)  5.0-10.5 





     
 
Figure 12. Exercise Duration (black circle) and Borg Dyspnea Ratings (grey bar) for 
the Athletes without PVFM (top) and the Athletes with PVFM (bottom). 
Discussion 
This study examined respiratory resistance for athletes with and without 
PVFM over repeated trials before and after a customized exercise-challenge test.  The 
primary findings before exercise were that: (1) Ri and Re were generally consistent 
across trials; (2) Ri was lower than Re for both groups; (3) Ri and Re were lower for 
athletes with PVFM than for those without PVFM.  After exercise, athletes without 
PVFM demonstrated a decrease in both Ri and Re, whereas athletes with PVFM 
demonstrated an increase in Ri and Re with a much greater change occurring for Ri. 




their dyspnea as substantially more severe than athletes without PVFM. These results 
are discussed in detail as follows and in relation to previous literature.  
Athletes without PVFM  
Results for this group demonstrated remarkably consistent values of Ri, Re, 
and Ri/Re during two 1-minute trials of RTB. Normative data for Rr obtained with the 
APD have been published for 534 individuals with unknown respiratory health 
conditions, of which 102 were between the ages of 12 and 18 years (Johnson et al., 
2007). Unfortunately, the data were reported by age groups, but not separated by sex. 
The average Ri and Re values in Johnson et al.’s (2007) study were 3.73 cmH2O/L/s 
and 4.26 cmH2O/L/s respectively, which are quite similar to the results during RTB 
(Ri = 3.92 cmH2O/L/s and Re = 4.40 cmH2O/L/s) for the female teen athletes without 
PVFM in the present study.  
Following exercise, Ri decreased slightly but significantly in athletes without 
PVFM.  This exercise effect was small in the first minute after exercise, a decrease of 
3.39% from RTB (when the two trials were averaged) to PEB1, yet continued to 
become more evident by the end of the second minute following exercise decreasing 
by10.1% from RTB to PEB2. Since these control athletes had participated in three 
separate exercise-challenge sessions, mean values for Ri from the second and third 
sessions were analyzed and revealed the same pattern (Session 2 PEB1: 3.75 
cmH2O/L/s, PEB2: 3.45 cmH2O/L/s; Session 3 PEB1: 3.7 cmH2O/L/s, PEB2: 3.51 
cmH2O/L/s).  
Ri reduction that continued into the second minute after exercise in this group 




Immediately prior to exercise cessation, the athletes provided their final dyspnea 
rating. They began their first post-exercise trial within 10 seconds.  They wore nose 
clips, secured their lips around the mouthpiece while they or the investigator held 
their cheeks to prevent air pocketing and air leakage around the mouthpiece. Despite 
their mild-to-moderate dyspnea ratings at the end of the exercise task, dyspnea may 
have increased markedly with the APD in place. This sense of discomfort likely 
lessened during the subsequent trial when breathing became less laborious. Several 
athletes commented on a claustrophobic feeling when using the APD immediately 
following exercise, while others were observed to show their discomfort by rapidly 
tapping their feet or drumming their fingers on the table while breathing into the 
APD. In response to feelings of dyspnea during PEB1, the athletes may have 
increased musculoskeletal tension of the upper torso and chest wall that could 
feasibly increase Rr. After a minute of recovery (PEB2), some of the athletes appeared 
more comfortable and later commented on a reduced sense of dyspnea. 
Silverman et al. (2005) measured respiratory resistance in 12, 18-40 year-old 
male and female non-asthmatic athletes before exercise and continuously for 6 
minutes immediately after exercise.  The results of their study indicated an “exercise 
effect” where Ri and Re both decreased following exercise cessation. Although 
athletes in both Silverman et al.’s (2005) study and the present study experienced a 
decrease in Ri, the pattern of change was not the same. Within the first minute 
following exercise cessation, Ri decreased the most in Silverman et al.’s study (2005), 




measured. Control athletes without PVFM in the present study experienced a greater 
decrease in Ri during PEB2 than PEB1.   
Differences in results between these two studies may derive from differences 
in participants and exercise protocols. The athletes in the present study were all girls 
at an average age of 14 years. Both sex and age affect the anatomy and physiology of 
the airways and the larynx. Johnson and colleagues (2007) found that APD-measured 
respiratory resistance followed a decreasing trend throughout childhood, stabilizing 
during early adulthood, and that Rr for adult males is approximately 80% that of adult 
females.  According to Sapienza and Huffman-Ruddy (2009), aspects of the larynx 
may not reach full maturity until the later teen years. Thus, it is possible that a 
teenage girl’s upper airway may not yet have the anatomical and physiological 
capability to make an immediate adjustment to the increased turbulence associated 
with strenuous aerobic exercise.  
There was also a difference in the exercise protocol between the present study 
and that of Silverman et al. (2005). Their treadmill exercise challenge aimed at 
achieving a “moderate exercise level” (p. 31) by first having the athletes participate in 
5 minutes of warm-up running (at 50-60% of their age-predicted maximum heart rate) 
followed by a period where the treadmill speed and incline were increased at 3-
minute intervals to reach 80–85% of the athlete’s age-predicted HRmax. Once 
achieved, athletes ran continuously for 6 minutes. Thus, the exercise challenge 
designed by Silverman et al (2005), required a longer time to complete and used heart 




study consistently used the same graded treadmill exercise challenge that was time 
limited, with the level of exercise becoming more difficult each minute.  
 The predicted decrease in Re from RTB to PEB1, trending towards complete 
recovery to pre-exercise levels by PEB2, was observed in the athletes without PVFM. 
These findings are in agreement with Silverman et al. (2005). Although the vocal 
folds were not observed during PEB in these studies, the decrease in Re is consistent 
with increased vocal fold abduction during expiration, as observed by Beaty et al. 
(1999), England and Bartlett (1982), and Hurbis and Schild (1991). 
The predicted decrease in the ratio of inspiratory to expiratory resistance 
immediately following exercise was not observed for the athletes without PVFM. 
Because the extent and course of change in Ri from RTB to PEB was not the same as 
that of Re, following exercise, Ri/Re increased for both trials of PEB. The change 
from RTB to PEB for Ri/Re was 25.1% for trial 1 and 13.22% for trial 2. Following 
exercise, Ri/Re was greater than 1.0 during the first trial and approximated 1.0 during 
the second trial. Thus, Ri/Re is sensitive to an exercise effect; however, it was not the 
negative change that was hypothesized.  
 Regarding the research questions for the athletes without PVFM, the results of 
this study demonstrated that: (1) Ri and Re decreased following exercise with the 
effect being more pronounced for Re; and (2) the exercise effect for Ri was smaller 
immediately following exercise (PEB1) and became more obvious one minute later 






Athletes with PVFM 
During the two trials of RTB when the athletes were not experiencing 
symptoms of PVFM, all three dependent variables were consistent. Ri was lower than 
Re suggesting that the vocal folds were abducted more during inspiration than during 
expiration.  This observation is expected with normal laryngeal function.  Following 
exercise, however, Ri and Re both increased significantly. Ri increased 50% from 
RTB to PEB1, and 24% from RTB to PEB2, demonstrating a decrease of 26% in Ri by 
the end of the second post exercise trial. This is congruent with reports from direct 
observation of changes in glottal area during exercise among athletes with PVFM 
(Beaty et al., 1999; Heinle et al., 2003; Tervonen et al., 2009). Templer and 
colleagues (1991) altered the glottic aperture of cadaver larynges and measured 
airflow rates.  The resistance to airflow increased as the cross-sectional area of the 
glottis decreased. The significant increase in Rr (especially Ri) in athletes with PVFM 
in the present study supports this inverse relationship between Rr and GA 
demonstrated in the first study of this dissertation project.  Furthermore, it is 
consistent with the reduction of GA that is expected during the inspiratory phase of 
symptomatic PVFM.  
Incomplete laryngeal maturation may be another contributing factor in 
constriction of the laryngeal airway, and therefore, increased respiratory resistance.  
Young athletes with PVFM may experience supraglottic collapse of the posterior 
laryngeal structures into the airway, often referred to laryngomalacia. The laryngeal 
cartilages of the pediatric larynx are more pliable and the arytenoid cartilages are 




into the airway during inspiration because of negative pressure induced by the 
Bernoulli principle (Sapienza & Huffman-Ruddy, 2009). 
Re also increased following exercise (18% and 13% from RTB to PEB1-2, 
respectively) in the athletes with PVFM.  However, the increase was substantially 
smaller than the change in Ri. This coincides with reports that PVFM impacts 
inspiration much more than expiration (Christopher & Morris, 2010; Divi et al., 2008; 
Hicks et al., 2008). Like Ri, the exercise effect on Re was most remarkable during 
PEB1. Post-exercise Ri/Re revealed statistically significant changes. Because of the 
greater magnitude of the change in Ri from RTB to PEB, Ri/Re becomes greater than 
1.0 in the athletes with PVFM.  
Results from the experimental group indicate that: (1) Rr increased following 
exercise presumably due to changes in GA, with a greater increase observed for Ri 
than for Re; and (2) the exercise effect for Ri and Re was larger immediately following 
exercise, and started to decrease by PEB2. 
Experimental and Control Group Comparison 
 At rest, the athletes with PVFM had lower respiratory resistances than the 
athletes without PVFM in the present study. This difference was surprising and 
cannot be explained by differences in sex, age, body size, and athletic experience 
between the two groups because they were well-matched in these characteristics. A 
hypothesis for this is discussed in Chapter 5. Additional research is needed to explore 
this issue further.   Following exercise, the groups differed significantly in Ri during 
PEB1 only, but not in Re. These data validated the complaints of athletes with PVFM 




PVFM ran for longer durations, which also indicates that they tolerated faster speeds 
and steeper inclines since these two factors increased progressively over time.  
Borg dyspnea ratings at the end of the exercise challenge test also differed 
significantly between the two athlete groups, although as stated previously, athletes 
with PVFM were requested to exercise until they rated their breathing difficulty as 8 
(7 is very severe and 9 is very, very severe). This could have artificially inflated their 
ratings because they knew they could stop exercising if they reported a dyspnea rating 
of 8, whereas the athletes without PVFM never reached a dyspnea rating of 8 within 
the allotted time limit. Some of the athletes in both groups stopped running, even 
though they gave low ratings on the Borg dyspnea scale. For example, three athletes 
with PVFM requested discontinuing exercise prior to reaching the requested Borg 
rating of 8. From the investigator’s questioning of athletes from both groups, it 
appeared that athletes with and without PVFM had difficulty rating breathlessness 
exclusive from other competing sensations such as muscle fatigue. This may have 
been caused by the scale itself, or the instruction about the scale that was provided 
them. Athletes in the experimental group seemed to use the scale to rate their PVFM 
symptoms; whereas to the athletes without PVFM, the scale represented 
breathlessness and/or exertion. A future approach, if using the Borg scale for 
experimental and control athletes is to have athletes from both groups exercise until 
they reach the same dyspnea rating (e.g., 7 severe dyspnea), and assess group 
differences in exercise duration.  
The modified Borg scale is commonly used to rate dyspnea in older children 




medication trials, as well as during exercise testing (McGrath, Pianosi, Unruh & 
Buckley, 2005; Wilson & Jones, 1989). Groslambert and Mahon (2006) found that 
children between the ages of 8 to 12 years can perceive 2-4 intensities of dyspnea and 
can separate dyspnea from other competing sensations during exertion. This suggests 
that using the Borg scale despite having written descriptors of the magnitude of 
dyspnea, may be too difficult of a task for adolescents who have not been pre-trained 
to use it during exercise.  
A different type of scale, the Dalhousie Dyspnea Scale (DDS), may have 
future application for dyspnea ratings for individuals with PVFM. It is pictorial and 
comprises three different and separate scales – chest tightness, throat tightness, and 
exertion, with 7 increments per scale (McGrath, Pianosi, Unruh, & Buckley, 2005). 
Ratings of throat tightness and exertion based upon the DDS, may further clarify the 
sensations experienced during exercise of athletes with and without PVFM.   
Regarding the research questions comparing the two athlete groups, it can be 
concluded that athletes with PVFM: 1) had significantly lower Ri and Re during both 
trials of RTB, but significantly higher Ri during PEB1 as compared with the athletes 
without PVFM; 2) were outperformed by the control group during the exercise 
challenge in terms of exercise duration; and 3) reported more severe dyspnea during 
exercise than athletes without PVFM.  
Caveats  
There are several limitations to this study. Ideally, Rr should be assessed 
during exercise rather than following exercise to truly capture the real-time exercise 




motion associated with running on a treadmill.  Therefore, it is limited to use when 
the participant is not exercising or is engaged in more stationary exercise such as a 
stationary bicycle. It is not known what effect, if any, the brief delay between 
stopping exercise and starting the APD has on Rr. Also, if Rr is significantly 
influenced by the requisite use of a mouthpiece and nose-clip, wearing an airtight 
mask that covers the mouth and nose might be more comfortable for the participants. 
This alteration comes with a critical disadvantage. The addition of the nasal airways 
would confound Rr measures because of the relatively small passageways and 
variability of the nasal airways. Finally, not all 12 athletes with PVFM were able to 
complete three PEB trials, resulting in the need to omit PEB3 from the statistical 
analyses. The Clinical Center at Loyola University Maryland does not always have a 
physician on site to immediately manage emergency situations. The investigator 
decided that the risk of traumatizing and perhaps endangering the participants in this 
study by requiring them to complete the third PEB trial when they indicated 
substantial discomfort outweighed the benefits.  
Conclusions 
This study demonstrated that APD-measured inspiratory and expiratory 
resistance differs across breathing conditions (rest versus exercise) and breathing 
trials in two groups of female teen athletes who either do or do not have PVFM.  The 
groups differed most during resting breathing for both Ri and Re, and immediately 
following exercise for Ri. Furthermore, the athletes with PVFM sensed more severe 




The protocol for the exercise challenge in the present study was appropriately 
challenging for both groups, yet successfully differentiated the two groups. The 
inspiratory- to expiratory- resistance ratio did not differentiate athlete groups as 
anticipated during RTB or PEB, and consequently can be omitted as a dependent 
variable from future studies on this topic. Finally, the APD appears to be an effective 
and noninvasive tool for investigating PVFM because it separately measures 
inspiratory and expiratory resistances which can indicate glottal area changes. When 
attempting to identify individuals with PVFM, this has advantages over averaging 
resistance across the breathing cycle as do most other respiratory-resistance 






Chapter 5:  General Discussion 
 
 
Review of the Research and Results 
 The overarching goal of this research is to validate an objective, non-invasive 
measure of respiratory resistance for identifying abnormal constriction of the 
laryngeal airway associated with paradoxical vocal fold motion disorder. To this end, 
three research questions were addressed: 1) Can the Airflow Perturbation Device 
provide valid and reliable measures of respiratory resistance in teenage female 
athletes with and without PVFM? 2) If so, does respiratory resistance for female 
athletes with PVFM disorder differ significantly from that of female athletes without 
PVFM disorder during resting breathing and following strenuous exercise? 3) Do the 
variables of exercise duration and dyspnea ratings, collected during an exercise 
challenge test, also separate the two groups of athletes?   
It is widely accepted that PVFM causes complaints of dyspnea because of 
glottal constriction that, in turn, impacts athletic performance. The pathophysiology 
for PVFM is unknown. What is known is that rigorous exercise can be a triggering 
stimulus for the condition in athletes. Prior to this dissertation research, other 
investigators have observed changes in glottal area during exercise by performing 
continuous laryngoscopy before and throughout exercise (Beaty et al., 1999; Heinle et 
al., 2003; Hurbis & Schild, 1991). From video-recorded laryngeal images, they 
measured changes in glottal area occurring during exercise for athletes with and 
without breathing disorders. There are drawbacks to this method. The procedure of 
laryngoscopy during exercise is uncomfortable for participants, carries increased 




frame-by-frame is very time consuming, limiting the number of participants studied. 
Thus the challenge for the present research was finding a less invasive and more 
efficient way to discern changes in glottal area. Respiratory resistance seemed 
plausible provided that inspiratory and expiratory resistances could be separately 
measured since athletes with PVFM typically report that dyspnea is worse during 
inspiration.  
The Airflow Perturbation Device, developed by Dr. Arthur Johnson and 
colleagues at University of Maryland, College Park, seemed a likely means for 
investigating respiratory resistance in athletes with PVFM. The APD had undergone 
several studies investigating its validity and limitations (Johnson & Sahota, 2004, 
Lausted & Johnson, 1999; Lopresti, et al., 2008); its capacity to separately measure 
inspiratory and expiratory resistance (Lausted & Johnson, 1999); and its application 
in healthy athletes following exercise (Silverman et al., 2005).  In order to use the 
APD for a new application – to detect changes occurring at the glottis in female teen 
athletes and make comparisons with a control group – it was necessary to 
preliminarily investigate the validity and test-retest reliability of the APD.  
The purpose of Study 1 was to determine that Rr measured by the APD was 
strongly correlated with glottal area. A healthy participant feigned breathing that is 
characteristic of severe PVFM while breathing into the APD and simultaneously 
undergoing transnasal flexible laryngoscopy. Three breathing cycles were analyzed 
by synchronizing and measuring glottal area images with respiratory resistance 
measures during inspiration and expiration. The results revealed a strong negative 




decreased glottal area was associated with increased respiratory resistance. This 
indicated that respiratory resistance, measured by the APD, could indirectly measure 
changes in glottal area caused by PVFM in athletes who do not have other competing 
respiratory diagnoses such as asthma.  
The purpose of Study 2 was to confirm test-retest reliability of the APD to 
consistently assess respiratory resistance during breathing before exercise and 
immediately after exercise. In order to assess post-exercise breathing, an exercise 
challenge protocol was developed that met three criteria: a) aerobically challenge 
female teen athletes with and without PVFM; b) trigger PVFM symptoms in athletes 
having the disorder; and c) meet safety guidelines for adolescent exercise tests 
(Fletcher et al., 2001; Paridon et al., 2006). No existing exercise challenge 
“prescription” existed from the literature review, only descriptions of types of 
exercise challenges and their associated applications (Thompson et al., 2010). These 
varied by protocol (duration at each speed and workload setting), exercise mode 
(treadmill versus cycle ergometer), and level of difficulty (range of exercise settings, 
or the desired end-heart rate).  
To achieve near-maximum heart rate by 12 minutes (the recommended 
extreme duration for pediatric exercise tests), a protocol was developed where speed 
or incline changed each minute. The treadmill was the preferred mode because both 
athlete groups participated in sports requiring running, and athletes with PVFM 
confirmed that their symptoms occur while running. Pilot testing determined that the 
range for speed, 4.0 mph – 7.0 mph, and incline, 0% - 4%, achieved the desired goals 




During the exercise challenge, the Modified Borg Dyspnea scale (Borg, 1998) 
was selected to monitor and quantify athletes’ perceptions of dyspnea. Athletes with 
and without PVFM were asked to rate their sense of breathlessness on the modified 
Borg Dyspnea Severity Scale before starting the exercise challenge, and then at 1-
minute intervals. When they sensed a change in severity, they were asked to say or 
use their fingers to designate a new rating (Mahler et al., 2001).  
After the exercise challenge and modified Borg Scale were deemed 
appropriate for female teen athletes with and without PVFM, Study 2 was conducted 
to determine the test-retest reliability of the APD for measuring respiratory resistance. 
Twelve healthy, teenage, female athletes with no signs or symptoms of PVFM 
participated in three separate exercise sessions. Three trials of respiratory resistance 
were measured before exercise and immediately after exercise during each session. 
Twelve female teen athletes with confirmed diagnoses of PVFM participated in one 
session during which three trials of respiratory resistance were measured during RTB. 
Results revealed strong test-retest reliability (p < .01) for inspiratory and expiratory 
resistance during resting tidal breathing for both groups of athletes. Immediately 
following exercise for athletes without PVFM, inspiratory and expiratory resistance 
measures remained highly reliable (p < .01) in trials of the same order across the three 
sessions. This suggests that respiratory resistance is consistent for each of these 
breathing conditions (resting tidal breathing and post-exercise breathing), and that the 
respiratory system responds to exercise in a consistent manner in healthy female 
athletes who do not have PVFM.  In addition to inspiratory and expiratory resistance, 




expiratory resistance (Rr), ratio of inspiratory to expiratory resistance (Ri/Re), and the 
change from RTB to PEB for inspiratory resistance (∆Ri), expiratory resistance (∆Re), 
mean of inspiratory and expiratory resistance (∆Rr), and ratio of inspiratory to 
expiratory resistance (∆ Ri/Re). Variables that were the most reliable and meaningful 
were retained for Study 3. These were Ri, Re, and Ri/Re.  
After establishing the reliability of APD-measured values of inspiratory and 
expiratory resistance and the ratio of inspiratory to expiratory resistance, Study 3 
investigated the effect of exercise within and between groups of athletes with and 
without PVFM. Two 1-minute trials of respiratory resistance were measured before 
and after an exercise challenge for the purpose of observing how resistance differed 
from rest and changed over a 2-minute post-exercise recovery course for each group. 
This study also investigated exercise duration and dyspnea ratings during the exercise 
challenge for each group of athletes.  
For athletes without PVFM (control group), both inspiratory and expiratory 
resistance decreased on average after the first post-exercise trial as compared with 
RTB, although statistical significance was only reached for expiratory resistance. By 
the end of the second 1-minute post-exercise trial, inspiratory resistance reached a 
statistically significant decrease when compared with RTB. In contrast, expiratory 
resistance began to increase, approaching that of RTB. The ratio of inspiratory-to-
expiratory resistance was < 1.0 during resting breathing, owing to a wider glottis 
during inspiration and laryngeal braking during expiration. Following exercise, this 
ratio increased significantly caused by a disproportionate decrease in expiratory as 




group exercised for an average duration of 11 minutes, with five athletes completing 
the 12-minute challenge, and reported an average dyspnea rating of 3.6, which is 
between moderate and somewhat severe.  
Athletes with PVFM significantly increased inspiratory resistance during both 
trials of post-exercise breathing as compared to RTB. By the end of the second trial of 
PEB, inspiratory resistance had decreased such that the change from RTB to PEB was 
50% for the first trial and 24% for the second trial. Expiratory resistance also 
increased significantly during PEB1 for the experimental group, although this increase 
(18%) was small when compared with that for inspiratory resistance. Most athletes 
with PVFM claim that once they stop exercising, their breathing becomes more 
comfortable. This claim was validated by the change in inspiratory resistance that 
occurred during the second minute following exercise cessation. The inspiratory- to-
expiratory resistance ratio of <1.0 during resting breathing for athletes with PVFM 
suggested normal vocal fold motion for inspiration and expiration when they did not 
experience symptoms of dyspnea.  Following exercise, the sharp increase in 
inspiratory resistance as compared with expiratory resistance resulted in a ratio that 
was >1.0. During the treadmill challenge, the athletes with PVFM exercised for an 
average of 9 minutes and none completed the exercise challenge. Their average 
dyspnea rating was 7 (severe). 
Study 3 revealed three overall differences between athletes with and without 
PVFM. First, athletes with PVFM had lower inspiratory and expiratory resistance 
values during resting breathing than athletes without PVFM. This difference appears 




were commensurate with those obtained for same-aged participants by Johnson and 
colleagues (2007). In the present study, a retrospective review of the laryngoscopic 
examinations performed on the athletes with PVFM by the investigator revealed that 
4 of 12 of them experienced exercise-induced laryngomalacia only, while six others 
experienced exercise-induced laryngomalacia followed by vocal fold adductory 
motion. The two remaining athletes experienced vocal fold adduction without 
laryngomalacia. For those athletes with laryngomalacia, during exercise, it appears 
that high airflow rates in conjunction with the Bernoulli effect causes prolapse of the 
laryngeal structures impeding the glottal airway. Presumably the malleable laryngeal 
structures might also act to enlarge the laryngeal airway during resting tidal 
breathing, thus contributing to the lower respiratory resistance values for the athletes 
with PVFM in this study. Further study of this phenomenon is indicated by increasing 
the control and experimental group sample sizes while maintaining careful health 
screening procedures. 
Second, following exercise, inspiratory but not expiratory resistance differed 
significantly between groups of athletes. These results validated the complaints from 
athletes with PVFM that they experience the most breathing difficulty during 
inspiration. Third, PVFM clearly impacted the experimental group’s performance 
during the exercise challenge causing them, on average, to stop two minutes sooner 
than the control group because of the greater severity of dyspnea.  
An additional finding initially appeared to indicate a difference between the 
groups, but in fact appears to reveal a similarity. Post-exercise inspiratory resistance 




change from the first to the second post-exercise measure was the same for both 
groups. By the second post-exercise breathing measure, athletes with PVFM 
decreased both inspiratory and expiratory resistance as compared to the first post-
exercise trial. This suggested that athletes with PVFM were recovering from glottal 
constriction and transitioning towards RTB, best illustrated by their inspiratory-to- 
expiratory resistance ratio that changed from 1.22 to 1.04 for PEB trials 1and 2, 
respectively. Athletes without PVFM, by PEB2 experienced a further decrease in 
inspiratory resistance while experiencing a modest increase in expiratory resistance. 
They too appeared to be recovering towards RTB levels, as evidenced by their 
inspiratory-to-expiratory resistance ratio that changed on average from 1.11 to 1.01 
for PEB trials 1 and 2, respectively. Thus, although PEB inspiratory resistance values 
differed significantly between the two groups, they showed a similar recovery pattern 
as the effects of exercise resolved.  
Method of Investigation: Limitations 
Specific limitations for each study were previously discussed as a part of that 
particular study, thus this section will address overall threats to validity.   
 Participants.  Athletes without PVFM (control group) were self-selected and 
screened at the initial interview for diagnoses and/or symptoms suggestive of PVFM, 
asthma or other respiratory conditions. Three athletes answered positively to several 
of these questions and they were excluded from the study. Laryngeal examinations to 
confirm normal laryngeal anatomy and physiology were not required for athletes to 
qualify for the control group. However, including this examination would have 




control group screening interview participated in two separate exercise challenges. 
The APD-measured respiratory resistance values following exercise for both sessions 
revealed a sharp increase in inspiratory resistance as compared with resting breathing 
that matched the profiles of athletes with PVFM. This athlete exercised for 10 
minutes during the first session and 11.5 minutes during the second session, with 
Borg dyspnea ratings of 4 and 5 respectively. When she returned for the third session 
she agreed to undergo a laryngeal examination immediately after exercise. The 
examination revealed exercise-induced laryngomalacia (a type of PVFM), even 
though she denied all symptoms suggestive of glottal constriction. Based upon the 
results of laryngoscopy she was excluded from the study. The finding that a 
completely asymptomatic athlete showed evidence of PVFM upon laryngoscopy 
supports conducting laryngeal examinations for control subjects. On the other hand, it 
provided serendipitous evidence that the APD may be useful for detecting subclinical 
PVFM.   
The second limitation for control participants is the remarkably different 
intervals between experimental sessions. The statistical mode between sessions was 7 
days; however, many of the athletes from the control group did not come at the 
scheduled intervals. This potentially impacted the study’s internal validity. When 
intervals between sessions exceeded two weeks, physical conditioning levels were 
subject to change if the athletes were between sports seasons or had started a different 
sport. Reasons for irregular attendance over three sessions included after-school 
sports practices, busy academic and extracurricular schedules, transportation 




though they received payment for each session that they attended. Nevertheless, high 
test-retest reliability was maintained in Study 2. 
 The third limitation for the control participants dealt with the repetition effects 
of exercise challenges. Some of the participants were highly competitive and 
announced that their goal at each session was to complete the exercise challenge. 
Others who had not completed it during the first session returned to the second and 
third sessions desiring to beat their previous time. On the contrary, a third group 
recognized how difficult the exercise challenge was during their first session, and 
seemed to want to discontinue exercise sooner with each subsequent session. This 
may have impacted post-exercise group results. For ethical and safety reasons, an 
athlete’s request to stop was one of the criteria for discontinuing exercise. Thus, this 
was honored for athletes without and with PVFM. Additional limitations of the study 
involving athletes with PVFM are associated with the exercise challenge procedures 
and the timing of APD use which will be discussed in the following section.  
  Procedure.  The Modified Borg Dyspnea Scale was used initially for athletes 
with PVFM for safety purposes and to establish a ceiling for discontinuing exercise. 
The Loyola Clinical Center is not equipped to perform continuous laryngoscopy 
during exercise, making a symptom severity rating scale the primary means for the 
athlete to communicate the intensity of dyspnea associated with the occurrence of a 
PVFM episode.  The Borg scale was chosen based upon a review of exercise studies 
(Borg, 1998; Elliott et al., 1991; Hajiro et al., 1998) and the extensive investigation 
leading to its development. The original scale comprises 20 ordinal ratings, but the 




for teenagers. “Dyspnea” and “breathlessness”, however, are terms that are difficult to 
describe accurately. The instruction given to both groups by the investigator was 
“Please rate how out of breath you feel.” Prior to beginning exercise, athletes with 
PVFM were instructed to continue exercising until they reached a Borg rating of 8 
(where a rating of 7 is severe, and 9 is very, very severe). The scale seemed to confuse 
some of the athletes with PVFM because they perceived feeling “out of breath” 
separately from feeling symptoms of PVFM. The investigator recognized the 
importance of giving better instructions for using the rating scale as the study 
progressed, but continued to use the same verbal instructions throughout the 
remainder of the study to maintain consistency. Overall, the Borg scale was not 
convincingly the best method for describing and rating breathlessness associated with 
PVFM. Teens’ accuracy of rating dyspnea may improve with a scale having fewer 
increments or a continuous scale, and by training teens to discriminate breathlessness 
from other competing stimuli that impact exercise performance. The Dalhousie 
Dyspnea Scale (DDS) (McGrath, Pianosi, Unruh & Buckley, 2005) may be an 
alternative to the Borg scale for children and adolescents with PVFM. It comprises a 
series of seven line drawings of the airway that illustrate incremental narrowing of the 
upper airway to indicate throat tightness (McGrath, Pianosi, Unruh & Buckley, 2005). 
The DDS will be piloted during future diagnostic exercise challenges with athletes 
referred with symptoms suggestive of PVFM.   
 The second procedural limitation also focuses on the attempt to elicit PVFM 
symptoms through a customized exercise protocol. The treadmill exercise test was 




cannot replicate the physical, cognitive, or emotional demands of competitive play, 
nor the physical environment where the sport is played. In the future, a portable, 
battery-powered model of the APD may be available that would allow in-situ research 
in the environments and conditions where the athletes practice and compete, in order 
to better understand the contributing factors for PVFM.  
 An additional consideration for future studies is whether the exercise 
challenge protocol can reliably trigger PVFM symptoms in male athletes. Although 
males were not included in this study, during the time of data collection, the 
investigator worked clinically with  three teenage male athletes (two participated in 
cross country, and one in football) whose PVFM symptoms could not be triggered 
using the same exercise protocol as in this study. Rather, they needed to sprint at high 
rates of speed before becoming symptomatic of PVFM which implies that a different 
protocol may be needed for high-level male athletes suspected of having PVFM.  
 Finally, the current model of the APD has inherent limitations. In Studies 2 
and 3, exercise breathing was assessed after exercise stopped rather than during 
exercise. The APD cannot be used while running on a treadmill because it operates on 
alternating electric current, cannot be secured properly during movement that is 
associated with exercise, and requires breathing through a mouthpiece that alters 
natural breathing. With some modifications, the APD will become cordless and 
operate on DC rather than AC power. To reduce the amount of motion associated 
with exercising on a treadmill, a bicycle ergometer can be used instead with the APD 
affixed to it. Johnson is currently investigating APD-measured respiratory resistance 




results with resistance values obtained immediately following exercise (A. T. 
Johnson, personal communication, December 27, 2011). Findings from this research 
will help to determine the critical timing for accurately measuring exercise-related 
respiratory resistance.  
Theoretical Implications 
This dissertation research was designed to capitalize upon previous reports 
that found that the average age of PVFM diagnosis is 14 years (Hicks et al., 2008; 
Powell et al., 2000; Sandage & Zelanzny, 2004), and that it often occurs during sports 
where the athlete is maximally engaged in play (Heinle et al., 2003; McFadden & 
Zawadski, 1996). The results support previous reports that PVFM impacts inspiration 
more than expiration (Christopher & Morris, 2010; Divi, et al., 2008; Hicks et al., 
2008), the PVFM symptoms quickly abate when exercise ceases (Beaty et al., 1999; 
Brugman & Simons, 1998; Rundell & Spiering, 2002), the symptoms correspond with 
the perception of dyspnea (Andrianopoulos et al., 2000; Hicks et al., 2008; Mathers-
Schmidt & Brilla, 2005), impacting exercise performance (Brugman & Simons, 1998; 
McFadden & Zawadski, 1996).  
For athletes who experience PVFM, exercise-induced laryngomalacia has 
often been described as the cause of dyspnea (Christopher & Morris, 2010; Heinle et 
al., 2003, Richter et al., 2008). The hypothesized etiologies of laryngomalacia include 
abnormal laryngeal and supraglottic neuromuscular tone (Beaty et al., 1999), tissue 
redundancy of the arytenoid cartilages (Richter et al., 2008), or poorly developed 
airway structures that tend to collapse during exercise because of increased airflow 




Christopher & Morris, 2010). Interviews with athletes with PVFM often reveal that 
they experienced occasional episodes suggestive of PVFM in elementary or middle 
school when on the playground or in physical education class. However, it is not until 
their early teens when they show the typical PVFM symptom pattern. This coincides 
with participating in sports more frequently, at higher levels of competition, and 
playing with faster (and often older) athletes. Presumably a structural or functional 
laryngeal abnormality goes undetected until the respiratory system and laryngeal 
airway are taxed by strenuous exercise.  These topics require additional investigation 
to support or refute clinical impressions and anecdotal reports. 
Exercise-induced PVFM represents one of several recognized types of PVFM 
(Christopher & Morris, 2010). Although exercise is a direct trigger for the symptoms, 
the mechanism that causes glottal constriction may vary from one athlete to another. 
Among participants with PVFM in the current study, two athletes experienced 
intermittent vocal fold adduction, while the others experienced laryngomalacia either 
followed by vocal fold adduction, or laryngomalacia without vocal fold adduction. 
Although the period of laryngeal visualization following exercise is brief, and 
dyspnea severity level cannot be equalized across athletes, it appears that there is 
more than one phenomenon occurring that compromises the laryngeal airway. 
Currently the same label, paradoxical vocal fold motion, is used to describe 
involuntary adduction of the vocal folds, prolapse of the supraglottic structures into 
the airway (laryngomalacia), and any combination therein, for which the shared 
symptom is intermittent dyspnea. Thus, an initial step is to clearly define the disorder 




various triggering stimuli and the associated pathophysiology can be better 
understood. A better understanding of PVFM will positively impact treatment 
decisions and techniques. 
Since PVFM disorder has traditionally been associated with partial or 
complete adduction of the vocal folds, treatment techniques have aimed to teach 
clients to volitionally abduct their vocal folds. The preferred treatment for PVFM is 
cognitive-behavioral therapy provided by speech-language pathologists (Brugman & 
Simons, 1998; Heinle et al., 2003; Sandage & Zelanzny, 2004).  Brugman and 
Simons (1998) described the goals of therapy as teaching patients “to retrain their 
bodies to breathe under stress and to de-program the maladaptive pattern of PVFM” 
(p. 72).  A brief summary of typical treatment techniques for PVFM and current 
understanding of their rationale follows.  
Treatment begins by providing education and awareness about normal 
laryngeal and respiratory anatomy and physiology during comfortable breathing and 
when experiencing symptoms of PVFM (Brugman & Simons, 1998; Mathers-
Schmidt, 2001; Pinho, Tsuji, Sennes, & Menezes, 1997). Education often attenuates 
fear that is associated with breathing difficulty (Sandage & Zelanzny, 2004). 
Behavioral techniques are aimed at retraining one’s breathing to be used 
preventatively or in response to the onset of PVFM symptoms. Using diaphragmatic 
breathing during inspiration reduces upper torso tension and is a direct contrast to 
upper-chest breathing that occurs during PVFM episodes (Pinho et al., 1997). It is 
hypothesized that increased motor drive to the diaphragm increases the abductor 




breathing increases the glottal aperture (Sapienza, 2008). Inhaling through the nose, 
rather than through the mouth, may facilitate breathing since transnasal breathing 
during inspiration is a brainstem reflex linked with maximal vocal fold abduction 
(Andrianopoulos et al., 2000; Koufman & Block, 2008). Exhaling through pursed lips 
has been recommended in order to create positive pressure at the lips thus reducing 
laryngeal constriction at the glottis (Hicks et al., 2008). Alternately, exhaling while 
making a sustained hissing sound serves to provide auditory feedback of airway 
patency, while distracting the individual from their PVFM symptoms (Brugman & 
Simons, 1998; Christopher et al., 1983; Martin et al., 1987). Panting has been 
recommended for acute symptom management (Andrianopoulos et al., 2000; 
Brugman & Simons, 1998). Additional cognitive and behavioral techniques involve 
awareness and release of upper torso and laryngeal muscle tension through 
progressive relaxation (Mathers-Schmidt, 2001; Sandage & Zelanzny, 2004) and 
laryngeal massage (Aronson, 1990; Roy & Leeper, 1993).  
Ever since Martin and colleagues (1987) pioneered the development of a 
treatment protocol for patients with PVFM, SLPs have continued to employ 
techniques from this protocol to PVFM treatment, despite unclear rationales for using 
the techniques and a lack of evidence for treatment efficacy. However, it is unknown 
if the same techniques designed to volitionally abduct the vocal folds are effective for 
exercise-induced laryngomalacia. Yet until the disorder is further clarified, there is no 
clear theoretical basis for the mechanism behind SLP-delivered therapy for PVFM. At 
best, qualitative and quantitative data from patient interviews and exercise challenges 




involving the APD supports the potential for APD-assisted quantitative assessment of 
PVFM.    
Clinical Implications 
Several diagnostic implications from this study have direct clinical 
application. The exercise challenge protocol appears to be a safe and effective way to 
trigger exercise-related PVFM symptoms in female teen athletes. Purposely triggering 
athletes’ symptoms through using the exercise challenge provided a safe opportunity 
for the athlete to “show” the investigator her symptoms. A potential disadvantage is 
that administering the exercise challenge requires minimally two staff members – one 
to stand beside the treadmill to adjust the speed and incline while also recording data, 
and the other to stand behind the treadmill to ensure safety and prepare for post-
exercise APD use.  
Also, the results revealed two important questions that should be asked by the 
diagnostician during the patient interview for differentially diagnosing PVFM, 
especially when laryngoscopy and/or respiratory resistance instrumentation is 
unavailable. One is whether it is harder to inhale or exhale when experiencing 
dyspnea. This may require that the patient demonstrate her breathing when 
experiencing dyspnea since she may be confused by respiratory terminology. 
Although the athletes in this study experienced an increase in both inspiratory and 
expiratory resistance following exercise, clearly the greater difference occurred 
during inspiration. Thus, athletes stating that both breathing phases are equally hard, 
or that it is harder to exhale than inhale, most likely do not have PVFM unless it is 




after exercise breathing become easier. For the athletes with PVFM in this study, by 
the end of the second post-exercise breathing trial, inspiratory resistance had 
decreased which coincided with the investigator’s observations that they were 
breathing more comfortably.  
 Finally, the APD may be useful for both diagnostic and treatment 
applications. It offers the potential to screen athletes (and non-athletes) complaining 
of dyspnea so that preliminary medical referrals can be made. It also may contribute 
to the collection of treatment-outcomes data by measuring changes in respiratory 
resistance over time for athletes with PVFM. The APD gives near-real-time measures 
of inspiratory and expiratory resistance with only a 5-second delay, making it 
potentially useful as a biofeedback device as well. Patients with PVFM can practice 
breathing techniques while simultaneously monitoring inspiratory and expiratory 
resistance using the APD. To have maximum utility, the APD needs to provide 
immediate data display, become cordless by running on rechargeable batteries, and 
store data without connecting to a computer so that it can be used as a stand-alone 
unit.  
Implications for Future Research 
This dissertation research has preliminarily shown that respiratory resistance 
can be quantified reliably and interpreted meaningfully in young athletes with PVFM. 
Currently, the results from Studies 2 and 3 may be generalized to teenage females 
who participate in a variety of sports and whose PVFM symptoms are triggered by 
exercise. Proposed studies that target diagnostic aspects of PVFM will be discussed 




Study 1 used a healthy participant feigning PVFM breathing to assess the 
validity of the APD to detect glottal area change during simultaneous laryngoscopy.  
This study should be repeated in patients with PVFM who demonstrate either 
laryngomalacia or glottal constriction or a combination of the two conditions to 
establish the validity and sensitivity of the APD in diagnosing PVFM.  This type of 
study will require transnasal flexible laryngoscopy with simultaneous APD-measured 
respiratory resistance during exercise. The changes in laryngeal airway and 
respiratory resistance during exercise would allow observation of airway physiology 
and respiratory response before, during, and after onset of PVFM. Because of the 
risks associated with transnasal laryngoscopy, this experiment needs to be conducted 
at a medical facility with emergency medical personnel present.  
With regard to furthering an understanding of differences between athletes 
with and without PVFM, Studies 2 and 3 should be replicated and expanded to 
include a larger sample of females. Study 2 revealed that during resting breathing, 
female athletes with PVFM had lower inspiratory and expiratory resistance than their 
matched controls without PVFM. This may imply an underlying difference in 
laryngeal anatomy and physiology. Studying a larger sample of teenage female 
athletes will verify this finding. A similar study of male athletes is also needed. 
Significantly more female athletes are referred for diagnosis and treatment of PVFM 
than males. Reported female-to-male ratios range from 2:1 (Hicks et al., 2008), to 4:1 
(Powell et al., 2000), to 9:1 (Patel et al., 2004). It is important to know the reasons for 
between-sex differences and whether treatment options would vary depending upon 




Athletes with exercise-induced PVFM are frequently misdiagnosed as having 
exercise-induced asthma (Andrianopoulos et al., 2000; Brugman & Simons, 1998; 
Mathers-Schmidt, 2001). To provide appropriate treatment and prevent unnecessary 
utilization of medical resources, a study should be conducted to assess APD-
measured respiratory resistance during resting tidal breathing and post-exercise 
breathing in female and male teenage athletes diagnosed with exercise-induced 
asthma.  This will provide insightful information regarding the differential diagnostic 
capability of the APD.  
For athletes with PVFM, especially those with laryngomalacia, longitudinal 
research will provide insight into whether the condition is related to immaturity of 
laryngeal structures and as such can be “outgrown.” This should be done by studying 
girls diagnosed with PVFM disorder beginning by age 14 and following them through 
high school, assessing laryngeal function and respiratory resistance during exercise in 
conjunction with height and weight measurements at 6-month intervals.  
PVFM has been reported in adult women who have reached maturity (Altman 
et al., 2000; Christopher et al., 1983; Gallivan et al., 1994; Gurevich-Uvena et al., 
2010; Newman et al., 1995). To determine if adult women with PVFM are more 
likely to have problems related to vocal fold movement, a study that compares them 
with teenage girls for the type of laryngeal obstruction may answer these questions 
and guide the treatment decision-making process.  
Diagnostic findings can influence the development of treatment techniques. 
Treatment outcomes for PVFM need to be researched. Quantitative and qualitative 




controlled clinical trials. The investigator conducted a pilot treatment study that 
provided a glimpse at the challenges associated with adopting various types of 
measures. Four teenage female athletes engaged in a standard behavioral treatment 
program focused on breathing techniques, while also providing qualitative (e.g., 
dyspnea ratings) and quantitative (APD) data. The qualitative data (self-reported 
ratings of practice, frequency and severity of symptoms, and sense of breathing 
control) from these four athletes suggested that practicing the breathing techniques 
learned during therapy was associated with the athletes’ sense of breathing control, 
and inversely related with self-reported frequency of PVFM symptoms. However, 
exercise duration and post-exercise respiratory resistance measures did not support 
the athletes’ self-reported improvement. The athletes were required to perform the 
exercise challenge test during each of the four or five sessions attended. The test was 
difficult for them and may have caused mounting performance anxiety with each 
subsequent test that negatively impacted exercise duration and respiratory resistance 
measures. Prior research has shown an association between anxiety and respiration 
patterns (i.e. increased respiratory rate, reduced respiratory depth, and decreased end-
tidal CO2) (Boiten et al., 1994). Likewise, anxiety is associated with increased 
musculoskeletal tension to which the larynx is vulnerable (Aronson, 1990).  Repeated 
trials of the exercise test may be comparable to the “white coat syndrome” where 
people experience hypertension caused by the anxiety of having their blood pressure 
taken at a medical doctor’s office (Glen, Elliott, Curzio, Lees, & Reid, 1996).  
With the capacity of APD to measure changes in the laryngeal airway 




from the present study suggests incorporating several changes for a better design: (1) 
selecting athlete participants who are active in their sport for minimally two 
consecutive seasons so that their level of athleticism remains consistent for a longer 
time frame; (2) requesting that they attend four sessions (including the initial 
diagnostic/treatment session) scheduled at 2 week intervals and providing an 
incentive for them to maintain regular attendance; (3) having a collaborator conduct 
the athlete interviews during the three treatment sessions (sessions 2-4) so that the 
researcher is blinded to the athletes’ ratings of PVFM status and the athlete does not 
have to tell her ratings directly to the researcher; (4) administering the exercise 
challenge test at the first and last sessions only, to reduce possible effects of anxiety 
on the results; and  (5) establishing an incentive-based method for athletes to 
document their daily therapy practice through an online survey or handwritten chart 
so that the amount and conditions of practice can be quantified for statistical analyses. 
Thus, a future treatment study will implement the proposed changes while retaining 
and refining the effective aspects of the pilot study.  
 
Conclusion 
In conclusion, through a series of three studies, this research validated an 
objective and non-invasive measure of respiratory resistance that may detect 
abnormal constriction of the laryngeal airway associated with paradoxical vocal fold 
motion disorder. This research demonstrated that (1) respiratory resistance measured 
by the Airflow Perturbation Device negatively correlates with glottal area (GA) 




reliability of APD-determined Rr for a control group of healthy female teenage 
athletes during resting tidal breathing (RTB) and post-exercise breathing (PEB); and 
(3) immediately following exercise, inspiratory resistance, exercise duration, and 
dyspnea ratings differ between healthy athletes without PVFM and athletes with 
PVFM matched for sex, age, and sport activity level.  
These findings set the foundations of a new method to study exercise-induced 
PVFM.  Inspiratory and expiratory resistance can be reliably and validly measured 
with the APD. Furthermore, symptoms of PVFM can be induced using a customized 
exercise protocol and monitored with a self-reported dyspnea rating scale. This, then, 
sets the basic methodology for future studies of exercise-induced PVFM and its 







Interview for Control Athletes who do not have PVFM  
 
 
Sport                                  Level of Play         Number of seasons 
participation 
 
1. JV    V   Club   Elite 1   2   3   year round 
2. JV    V   Club   Elite 1   2   3   year round 
3. JV    V   Club   Elite 1   2   3   year round 
 
Sport(s) currently participating in___________________________ 
 
 
When exercising do you regularly experience any of the following? (Please assign 
severity (S) and frequency (F) ratings for each symptom from the table below) 
 
Feeling Rating Feeling Rating 
 





























0 No problem 
1 Had breathing difficulty, but continued activities at the same pace and 
intensity 
2 Had to slow down temporarily because of breathing difficulty; but remained 
in play 
3 Had to come out of play; breathing difficulty lasted shorter than 5 minutes 
4 Had to come out of play, felt scared and lacking control of symptoms; 
breathing difficulty lasted 5-10 minutes 
5 Had to come out of play, felt panic and no control of symptoms; breathing 








Medical/Psychological History - conditions that have been diagnosed by a medical 












Attention deficit disorder 
 




Other Medical Other Psychological 
 
What medications are currently being taken for the above conditions? Indicate when 
you last took each of these medications. 
  









Rate your health today (please circle) 
 
Fine OK Not feeling well Sick 
     
 
If you are willing to share your race and ethnicity, please circle the appropriate 
category(ies). 
 
Native American Asian Black/African American 
Hispanic  White  Native Pacific Islander 







 Interview for Athletes Referred for Paradoxical Vocal Fold Motion Disorder 
1.  History of the problem: 
 
2.  Under what conditions does PVFM occur? 
 Exercise   yes   /   no      
Sports played:                       Level:                     Seasons/yr: 
Sports where PVFM is experienced: 
Conditions where PVFM occurs:  practice        competition 
 Non-exercise  yes  /  no   what conditions? 
 
3.  Identify symptoms: 
Harder to breathe   in  / out / both  Dizziness       yes   /   no 
Stridor    yes  /  no                                  Numbness/tingling  yes / no 
Throat tightness   yes  /  no                Cough    yes   /   no                
 Voice Change/Loss during episode   yes   /  no   
 
4.  Rate the usual severity of your episode:  
Mild: aware of breathing difficulty but can continue at my current activity 
level 
Mild-Moderate: breathing difficulty interferes with activity requiring me to 
slow or stop; I stay on the field or in the pool 
Moderate: symptoms interfere, requiring me to stop my activity and request 
time out; ≤ 5 min. recovery time needed before comfortable breathing returns 
Moderate-Severe: symptoms require stopping activity, I feel scared and have a 
reduced sense of control of my breathing; > 5 but ≤ 10 minutes needed before 
comfortable breathing returns 
Severe: symptoms require stopping activity, I feel a sense of panic and a lack 
of control of my breathing no sense of control of breathing; > 10 minutes 
needed before comfortable breathing returns. 
5.  Rate the frequency of your episodes: 
 1.  Seldom: rarely happens when I exercise at a hard level 
2 – Occasional: happens occasionally when I exercise at a hard level 
3.  Sometimes: happens about half of the time I exercise at a hard level 
4 – Frequent: happens almost every time I exercise at a hard level 
5 - Very frequent: happens every time I exercise at a hard level (games & 
practices) 
 
6.  Rate your sense of control that you feel during a usual episode?  
 
4 (full control) 
100% 
3 (almost 
full  control) 
75%  
2 (moderate control)  
50% 
1 (some control) 
25% 
0 (no control) 
0 – 10% 





8.  Do the symptoms begin suddenly or gradually? (Estimate time from warning signs 
until episode) 
 
9.  Describe a usual episode. Describe your most severe episode. Have you required 
emergency intervention?   
     
 10.  Do you experience repeat episodes within the same practice or game?     
             
11.  Are you currently using asthma medications? Do they seem to help? 
 
12.  What do you do to stop an episode?  How long does it take for symptoms to 
subside? 
              
 MEDICAL HISTORY 
1.  Indicate the specialists that have been consulted for this problem: 
                                          
Asthma/Allergist            Pulmonologist   Gastroenterologist   




2.  Indicate concurrent medical conditions: 
Asthma Post-nasal drip Shin splints 
Allergies Heart problem Joint problems 
Reflux Back problem Chronic cough 
Hoarseness Depression Anxiety 
Other:   







Exercise Challenge Data Recording Form 
Participant Number:                           Date:                                        Session #  
 
Group: PVFM____   Control: ____  
 
Age: ________   Height: ________   Weight:________ HR max 
___________________  
 
Consent signed:   yes/no     Assent signed:  yes/ no        Questionnaire completed:  
yes/ no 
 
Name of Grad SLP assistant:   
                  




















0-1  min. 4.0 0%   
1-2 min. 4.0 1%   
2-3 min. 5.0 1%   
3-4  5.0 2%   
4-5  5.5 2%   
5-6  5.5 3%   
6-7  6.0 3%   
7-8  6.0 4%   
8-9 6.5 4%   
9-10 6.5 4%   
10-11 7.0 4%   
11-12 7.0 4%   
Post-exercise 3 min.      
 






List of Abbreviations 
∆Rr%  Change in respiratory resistance measured in percent 
APD Airflow Perturbation Device 
CCC Cross correlation coefficient 
E-IA Exercise-induced asthma 
GA Glottal area 
GERD Gastro-esophageal reflux disease 
ICC Intraclass correlation coefficient 
LCC Loyola University Clinical Centers 
LPR Laryngo-pharyngeal reflux 
PEB Post-exercise breathing 
PFTs Pulmonary function tests 
PVFM Paradoxical vocal fold motion 
R Mean of inspiratory and expiratory resistance 
Re Expiratory resistance 
Ri Inspiratory resistance 
Ri/Re Ratio of inspiratory to expiratory resistance 
Rr Respiratory resistance 
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